RxNorm Semantic Concepts Index - 256
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "256".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 2560084 | ephedrine hydrochloride 4.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2560084 | ephedrine hydrochloride 4.7 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560085 | ePHEDrine hydrochloride 23.5 MG in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2560085 | ePHEDrine hydrochloride 23.5 MG in 5 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560085 | ePHEDrine hydrochloride 23.5 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560085 | ePHEDrine hydrochloride 23.5 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560085 | ePHEDrine hydrochloride 23.5 MG in 5 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560085 | ePHEDrine hydrochloride 23.5 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560085 | ePHEDrine hydrochloride 23.5 MG in 5 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560086 | Rezipres | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2560087 | ephedrine hydrochloride 4.7 MG/ML [Rezipres] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2560087 | ephedrine hydrochloride 4.7 MG/ML [Rezipres] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560088 | ephedrine Injection [Rezipres] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2560088 | ephedrine Injection [Rezipres] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560089 | Rezipres Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2560090 | REZIPRES 23.5 MG in 5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2560090 | REZIPRES 23.5 MG in 5 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560090 | REZIPRES 23.5 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560090 | REZIPRES 23.5 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560090 | REZIPRES 23.5 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560091 | ephedrine hydrochloride 4.7 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560091 | ephedrine hydrochloride 4.7 MG/ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560092 | ephedrine hydrochloride 4.7 MG/ML Injection [Rezipres] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2560092 | ephedrine hydrochloride 4.7 MG/ML Injection [Rezipres] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560092 | ephedrine hydrochloride 4.7 MG/ML Injection [Rezipres] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560093 | ephedrine hydrochloride 47 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2560093 | ephedrine hydrochloride 47 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560094 | ePHEDrine hydrochloride 47 MG in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560094 | ePHEDrine hydrochloride 47 MG in 1 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560094 | ePHEDrine hydrochloride 47 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560094 | ePHEDrine hydrochloride 47 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560094 | ePHEDrine hydrochloride 47 MG in 1 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560095 | ephedrine hydrochloride 47 MG/ML [Rezipres] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2560095 | ephedrine hydrochloride 47 MG/ML [Rezipres] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560096 | REZIPRES 47 MG in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2560096 | REZIPRES 47 MG in 1 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560096 | REZIPRES 47 MG in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560096 | REZIPRES 47 MG in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560097 | ephedrine hydrochloride 47 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560097 | ephedrine hydrochloride 47 MG/ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560098 | ephedrine hydrochloride 47 MG/ML Injection [Rezipres] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2560098 | ephedrine hydrochloride 47 MG/ML Injection [Rezipres] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560098 | ephedrine hydrochloride 47 MG/ML Injection [Rezipres] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560099 | ephedrine hydrochloride 9.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2560099 | ephedrine hydrochloride 9.4 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560100 | ePHEDrine hydrochloride 47 MG in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560100 | ePHEDrine hydrochloride 47 MG in 5 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560100 | ePHEDrine hydrochloride 47 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560100 | ePHEDrine hydrochloride 47 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560100 | ePHEDrine hydrochloride 47 MG in 5 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560100 | ePHEDrine hydrochloride 47 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560100 | ePHEDrine hydrochloride 47 MG in 5 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560101 | ephedrine hydrochloride 9.4 MG/ML [Rezipres] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2560101 | ephedrine hydrochloride 9.4 MG/ML [Rezipres] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560102 | REZIPRES 47 MG in 5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2560102 | REZIPRES 47 MG in 5 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560102 | REZIPRES 47 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560102 | REZIPRES 47 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560102 | REZIPRES 47 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560103 | ephedrine hydrochloride 9.4 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560103 | ephedrine hydrochloride 9.4 MG/ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560104 | ephedrine hydrochloride 9.4 MG/ML Injection [Rezipres] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2560104 | ephedrine hydrochloride 9.4 MG/ML Injection [Rezipres] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560104 | ephedrine hydrochloride 9.4 MG/ML Injection [Rezipres] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560105 | Alpinia nigra root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2560106 | citric acid isopropyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2560107 | Commiphora myrrha stem bark | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2560110 | Stevia eupatoria whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2560111 | Bilovet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2560112 | tylosin 200 MG/ML [Bilovet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2560113 | tylosin Injectable Solution [Bilovet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2560114 | Bilovet Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2560115 | BiloVet 200 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560115 | BiloVet 200 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560115 | BiloVet 200 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2560213 | ibrexafungerp | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2560214 | 3'-hydroxyacetophenone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2560215 | ibrexafungerp citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2560216 | ibrexafungerp 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2560217 | ibrexafungerp Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2560218 | ibrexafungerp Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2560219 | ibrexafungerp Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2560220 | ibrexafungerp 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560220 | ibrexafungerp 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560220 | ibrexafungerp 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2560221 | Brexafemme | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2560222 | ibrexafungerp 150 MG [Brexafemme] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2560223 | ibrexafungerp Oral Tablet [Brexafemme] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2560224 | Brexafemme Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2560225 | Brexafemme Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2560226 | BREXAFEMME 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560226 | BREXAFEMME 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560226 | BREXAFEMME 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2560228 | sodium benzoate 10 % / sodium phenylacetate 10 % in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2560228 | sodium benzoate 10 % / sodium phenylacetate 10 % in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560228 | sodium benzoate 10 % / sodium phenylacetate 10 % in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560229 | tris(N-hydroxyethyl)hexahydrotriazine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2560230 | quaternium-90 bentonite | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2560233 | bupivacaine / meloxicam Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2560233 | bupivacaine / meloxicam Injectable Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560235 | salicylic acid 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560235 | salicylic acid 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560235 | salicylic acid 1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560236 | C15-19 alkane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2560237 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG Oral Tablet) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2560237 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG Oral Tablet) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560237 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG Oral Tablet) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560237 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG Oral Tablet) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560237 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG / triprolidine HCl 1.25 MG Oral Tablet) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560238 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / triprolidine HCl 1.25 MG Oral Tablet) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2560238 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / triprolidine HCl 1.25 MG Oral Tablet) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560238 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / triprolidine HCl 1.25 MG Oral Tablet) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560238 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / triprolidine HCl 1.25 MG Oral Tablet) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560238 | 1 daytime (dextromethorphan HBr 10 MG / guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / triprolidine HCl 1.25 MG Oral Tablet) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560239 | benzocaine 70 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2560240 | benzocaine 7 % / menthol 1 % Mucosal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560240 | benzocaine 7 % / menthol 1 % Mucosal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560240 | benzocaine 7 % / menthol 1 % Mucosal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2560246 | Niravi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2560247 | lidocaine 0.04 MG/MG [Niravi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2560248 | lidocaine Medicated Patch [Niravi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2560249 | Niravi Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2560250 | Niravi 4 % Medicated Patch | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2560250 | Niravi 4 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560250 | Niravi 4 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560251 | ibrexafungerp 150 MG (4) Oral Tablet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2560251 | ibrexafungerp 150 MG (4) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560251 | ibrexafungerp 150 MG (4) Oral Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560252 | Brexafemme Kit | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2560252 | Brexafemme Kit | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560252 | Brexafemme Kit | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560305 | Zynrelef Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2560306 | ZYNRELEF (BUPivacaine 200 MG / meloxicam 6 MG) in 7 ML Extended Release Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2560306 | ZYNRELEF (BUPivacaine 200 MG / meloxicam 6 MG) in 7 ML Extended Release Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560306 | ZYNRELEF (BUPivacaine 200 MG / meloxicam 6 MG) in 7 ML Extended Release Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560306 | ZYNRELEF (BUPivacaine 200 MG / meloxicam 6 MG) in 7 ML Extended Release Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560306 | ZYNRELEF (BUPivacaine 200 MG / meloxicam 6 MG) in 7 ML Extended Release Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560307 | bupivacaine 29.3 MG/ML / meloxicam 0.88 MG/ML [Zynrelef] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2560307 | bupivacaine 29.3 MG/ML / meloxicam 0.88 MG/ML [Zynrelef] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560308 | ZYNRELEF (BUPivacaine 400 MG / meloxicam 12 MG) in 14 ML Extended Release Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2560308 | ZYNRELEF (BUPivacaine 400 MG / meloxicam 12 MG) in 14 ML Extended Release Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560308 | ZYNRELEF (BUPivacaine 400 MG / meloxicam 12 MG) in 14 ML Extended Release Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560308 | ZYNRELEF (BUPivacaine 400 MG / meloxicam 12 MG) in 14 ML Extended Release Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560308 | ZYNRELEF (BUPivacaine 400 MG / meloxicam 12 MG) in 14 ML Extended Release Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560309 | ZYNRELEF (BUPivacaine 300 MG / meloxicam 9 MG) in 10.5 ML Extended Release Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2560309 | ZYNRELEF (BUPivacaine 300 MG / meloxicam 9 MG) in 10.5 ML Extended Release Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560309 | ZYNRELEF (BUPivacaine 300 MG / meloxicam 9 MG) in 10.5 ML Extended Release Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560309 | ZYNRELEF (BUPivacaine 300 MG / meloxicam 9 MG) in 10.5 ML Extended Release Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560309 | ZYNRELEF (BUPivacaine 300 MG / meloxicam 9 MG) in 10.5 ML Extended Release Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560310 | bupivacaine / meloxicam | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2560310 | bupivacaine / meloxicam | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560311 | ZYNRELEF (BUPivacaine 60 MG / meloxicam 1.8 MG) in 2.3 ML Extended Release Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2560311 | ZYNRELEF (BUPivacaine 60 MG / meloxicam 1.8 MG) in 2.3 ML Extended Release Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560311 | ZYNRELEF (BUPivacaine 60 MG / meloxicam 1.8 MG) in 2.3 ML Extended Release Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560311 | ZYNRELEF (BUPivacaine 60 MG / meloxicam 1.8 MG) in 2.3 ML Extended Release Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560311 | ZYNRELEF (BUPivacaine 60 MG / meloxicam 1.8 MG) in 2.3 ML Extended Release Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560312 | BUPivacaine 400 MG / meloxicam 12 MG in 14 ML Extended Release Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2560312 | BUPivacaine 400 MG / meloxicam 12 MG in 14 ML Extended Release Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560312 | BUPivacaine 400 MG / meloxicam 12 MG in 14 ML Extended Release Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560312 | BUPivacaine 400 MG / meloxicam 12 MG in 14 ML Extended Release Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560312 | BUPivacaine 400 MG / meloxicam 12 MG in 14 ML Extended Release Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560313 | bupivacaine 29.3 MG/ML / meloxicam 0.88 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560313 | bupivacaine 29.3 MG/ML / meloxicam 0.88 MG/ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560314 | bupivacaine 29.3 MG/ML / meloxicam 0.88 MG/ML Injection [Zynrelef] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2560314 | bupivacaine 29.3 MG/ML / meloxicam 0.88 MG/ML Injection [Zynrelef] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2560315 | BUPivacaine 300 MG / meloxicam 9 MG in 10.5 ML Extended Release Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2560315 | BUPivacaine 300 MG / meloxicam 9 MG in 10.5 ML Extended Release Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560315 | BUPivacaine 300 MG / meloxicam 9 MG in 10.5 ML Extended Release Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560315 | BUPivacaine 300 MG / meloxicam 9 MG in 10.5 ML Extended Release Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560315 | BUPivacaine 300 MG / meloxicam 9 MG in 10.5 ML Extended Release Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560316 | bupivacaine / meloxicam Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2560316 | bupivacaine / meloxicam Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560317 | bupivacaine / meloxicam Injection [Zynrelef] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2560317 | bupivacaine / meloxicam Injection [Zynrelef] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560319 | BUPivacaine 60 MG / meloxicam 1.8 MG in 2.3 ML Extended Release Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2560319 | BUPivacaine 60 MG / meloxicam 1.8 MG in 2.3 ML Extended Release Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560319 | BUPivacaine 60 MG / meloxicam 1.8 MG in 2.3 ML Extended Release Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560319 | BUPivacaine 60 MG / meloxicam 1.8 MG in 2.3 ML Extended Release Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560319 | BUPivacaine 60 MG / meloxicam 1.8 MG in 2.3 ML Extended Release Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560321 | BUPivacaine 200 MG / meloxicam 6 MG in 7 ML Extended Release Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2560321 | BUPivacaine 200 MG / meloxicam 6 MG in 7 ML Extended Release Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560321 | BUPivacaine 200 MG / meloxicam 6 MG in 7 ML Extended Release Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2560321 | BUPivacaine 200 MG / meloxicam 6 MG in 7 ML Extended Release Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2560321 | BUPivacaine 200 MG / meloxicam 6 MG in 7 ML Extended Release Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560323 | meloxicam 0.88 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2560324 | Zynrelef | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2560325 | bupivacaine 29.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2560325 | bupivacaine 29.3 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2560400 | acefylline methylsilanol mannuronate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 25605 | 6,9,12-octadecatrienoic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 25605 | 6,9,12-octadecatrienoic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 25605 | 6,9,12-octadecatrienoic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 25605 | 6,9,12-octadecatrienoic acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 25605 | 6,9,12-octadecatrienoic acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 25605 | 6,9,12-octadecatrienoic acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 25605 | 6,9,12-octadecatrienoic acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2560505 | hard maple pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560506 | hard maple pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560506 | hard maple pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560506 | hard maple pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560506 | hard maple pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560507 | redroot pigweed pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560507 | redroot pigweed pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560507 | redroot pigweed pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560508 | sheep sorrel pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560509 | sheep sorrel pollen extract 10,000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560509 | sheep sorrel pollen extract 10,000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560509 | sheep sorrel pollen extract 10,000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560510 | corn pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560511 | corn pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560511 | corn pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560511 | corn pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560512 | American elm pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560513 | American elm pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560513 | American elm pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560513 | American elm pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560514 | western ragweed pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560515 | western ragweed pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560515 | western ragweed pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560515 | western ragweed pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560516 | yellow dock pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560517 | yellow dock pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560517 | yellow dock pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560517 | yellow dock pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560518 | European olive pollen extract 1000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560518 | European olive pollen extract 1000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560518 | European olive pollen extract 1000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560519 | English plantain pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560520 | English plantain pollen extract 1000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560520 | English plantain pollen extract 1000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560520 | English plantain pollen extract 1000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560521 | black willow pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560522 | black willow pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560522 | black willow pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560522 | black willow pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560523 | California black walnut pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560524 | California black walnut pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560524 | California black walnut pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560524 | California black walnut pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560525 | box elder maple pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560526 | box elder maple pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560526 | box elder maple pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560526 | box elder maple pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560527 | white oak pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560528 | white oak pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560528 | white oak pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560528 | white oak pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560528 | white oak pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560529 | hazelnut pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560530 | hazelnut pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560530 | hazelnut pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560530 | hazelnut pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560531 | black walnut pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560532 | black walnut pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560532 | black walnut pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560532 | black walnut pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560533 | red mulberry pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560534 | red mulberry pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560534 | red mulberry pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560534 | red mulberry pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560535 | saltbush pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560536 | saltbush pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560536 | saltbush pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560536 | saltbush pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560537 | saltbush pollen extract 20,000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560537 | saltbush pollen extract 20,000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560537 | saltbush pollen extract 20,000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560538 | shagbark hickory pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560539 | shagbark hickory pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560539 | shagbark hickory pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560539 | shagbark hickory pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560540 | smooth brome pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560541 | smooth brome pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560541 | smooth brome pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560541 | smooth brome pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560542 | plains cottonwood pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560543 | plains cottonwood pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560543 | plains cottonwood pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560543 | plains cottonwood pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560543 | plains cottonwood pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560544 | white poplar pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560545 | white poplar pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560545 | white poplar pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560545 | white poplar pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560546 | lambs quarters pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560547 | lambs quarters pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560547 | lambs quarters pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560547 | lambs quarters pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560548 | common sagebrush pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560549 | common sagebrush pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560549 | common sagebrush pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560549 | common sagebrush pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560550 | burning bush pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560551 | burning bush pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560551 | burning bush pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560551 | burning bush pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560551 | burning bush pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560552 | perennial rye grass pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560552 | perennial rye grass pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560552 | perennial rye grass pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560553 | smooth brome pollen extract 20,000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560553 | smooth brome pollen extract 20,000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560553 | smooth brome pollen extract 20,000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560554 | cultivated oat pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560555 | cultivated oat pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560555 | cultivated oat pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560555 | cultivated oat pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560556 | Johnson grass pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560557 | Johnson grass pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560557 | Johnson grass pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560557 | Johnson grass pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560557 | Johnson grass pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560558 | pecan pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560559 | pecan pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560559 | pecan pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560559 | pecan pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560702 | Selaginella lepidophylla whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2560703 | dioctyldodecyl lauroyl glutamate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2560710 | giant ragweed pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560711 | giant ragweed pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560711 | giant ragweed pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560711 | giant ragweed pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560712 | giant ragweed pollen extract 20,000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560712 | giant ragweed pollen extract 20,000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560712 | giant ragweed pollen extract 20,000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560713 | short ragweed pollen extract 20000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560713 | short ragweed pollen extract 20000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560713 | short ragweed pollen extract 20000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560714 | false ragweed pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560715 | false ragweed pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560715 | false ragweed pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560715 | false ragweed pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560716 | eastern sycamore pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560717 | eastern sycamore pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560717 | eastern sycamore pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560717 | eastern sycamore pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560717 | eastern sycamore pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560720 | western sycamore pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560721 | western sycamore pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560721 | western sycamore pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560721 | western sycamore pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560722 | English plantain pollen extract 10 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560722 | English plantain pollen extract 10 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560722 | English plantain pollen extract 10 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560723 | English plantain pollen extract 100 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560723 | English plantain pollen extract 100 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560723 | English plantain pollen extract 100 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560724 | English plantain pollen extract 10,000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560724 | English plantain pollen extract 10,000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560724 | English plantain pollen extract 10,000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560725 | cherry birch pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560726 | cherry birch pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560726 | cherry birch pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560726 | cherry birch pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560727 | European olive pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560727 | European olive pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560727 | European olive pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560728 | live oak pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560729 | live oak pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560729 | live oak pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560729 | live oak pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560730 | mugwort sage pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560731 | mugwort sage pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560731 | mugwort sage pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560731 | mugwort sage pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560732 | rough cocklebur pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560732 | rough cocklebur pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560732 | rough cocklebur pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560733 | Russian thistle pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560734 | Russian thistle pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560734 | Russian thistle pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560734 | Russian thistle pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560734 | Russian thistle pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560735 | Siberian elm pollen extract Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2560736 | Siberian elm pollen extract 10000 UNT/mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560736 | Siberian elm pollen extract 10000 UNT/mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2560736 | Siberian elm pollen extract 10000 UNT/mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560737 | menthol 14 % / methyl salicylate 15 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2560737 | menthol 14 % / methyl salicylate 15 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2560737 | menthol 14 % / methyl salicylate 15 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 25608 | oryzanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 25608 | oryzanol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 25608 | oryzanol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 25608 | oryzanol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 25608 | oryzanol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2561 | Condensing enzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2561 | Condensing enzyme | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2561 | Condensing enzyme | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2561 | Condensing enzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2561 | Condensing enzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2561 | Condensing enzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 25610 | Gamma-renin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 25610 | Gamma-renin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2561243 | barium bromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2561244 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2561249 | asparaginase Erwinia chrysanthemi (recombinant)-rywn | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2561250 | asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2561251 | asparaginase Erwinia chrysanthemi (recombinant)-rywn 10 MG per 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2561251 | asparaginase Erwinia chrysanthemi (recombinant)-rywn 10 MG per 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2561251 | asparaginase Erwinia chrysanthemi (recombinant)-rywn 10 MG per 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2561252 | Rylaze | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2561253 | asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML [Rylaze] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2561254 | asparaginase Injection [Rylaze] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2561255 | Rylaze Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2561256 | RYLAZE 10 MG in 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2561256 | RYLAZE 10 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2561256 | RYLAZE 10 MG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2561256 | RYLAZE 10 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2561257 | asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2561258 | asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML Injection [Rylaze] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2561258 | asparaginase Erwinia chrysanthemi (recombinant)-rywn 20 MG/ML Injection [Rylaze] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2561263 | Fluarix Quadrivalent 2021-2022 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2561264 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluarix Quadrivalent 2021-2022] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2561265 | Flulaval Quadrivalent 2021-2022 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2561266 | influenza virus vaccine 2021-2022 (quadrivalent - Tasmania/Victoria/Phuket/Washington) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2561266 | influenza virus vaccine 2021-2022 (quadrivalent - Tasmania/Victoria/Phuket/Washington) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2561266 | influenza virus vaccine 2021-2022 (quadrivalent - Tasmania/Victoria/Phuket/Washington) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2561267 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluarix Quadrivalent 2021-2022] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2561270 | FLULAVAL QUADRIVALENT 2021-2022 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2561270 | FLULAVAL QUADRIVALENT 2021-2022 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2561270 | FLULAVAL QUADRIVALENT 2021-2022 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2561271 | Flulaval Quadrivalent 2021-2022 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2561272 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2561275 | FLUARIX QUADRIVALENT 2021-2022 vaccine 0.5 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2561275 | FLUARIX QUADRIVALENT 2021-2022 vaccine 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2561275 | FLUARIX QUADRIVALENT 2021-2022 vaccine 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2561276 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2561278 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Flulaval Quadrivalent 2021-2022] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2561279 | Fluarix Quadrivalent 2021-2022 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2561280 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Flulaval Quadrivalent 2021-2022] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2561285 | propofol lipid emulsion 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2561287 | propofol lipid emulsion 20 MG/ML [Propoven] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2561291 | propofol lipid emulsion 10 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2561292 | propofol lipid emulsion 10 MG/ML [Propoven] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2561294 | vitamin E 22.6 MG/ML [Aquasol E] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2561296 | vitamin E 22.6 MG/ML [Aquavite-E] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2561527 | Aloe emodin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 25617 | UDPgalactose-ceramide galactosyltransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 25617 | UDPgalactose-ceramide galactosyltransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 25617 | UDPgalactose-ceramide galactosyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2562 | Calcium cyanamide citrated | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2562 | Calcium cyanamide citrated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2562 | Calcium cyanamide citrated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2562108 | olanzapine / samidorphan | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2562108 | olanzapine / samidorphan | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2562173 | PEG-75 dilaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2562174 | PLPP1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2562174 | PLPP1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2562175 | piperazine dihydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2562176 | serdexmethylphenidate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2562176 | serdexmethylphenidate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2562176 | serdexmethylphenidate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2562177 | serdexmethylphenidate chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2562177 | serdexmethylphenidate chloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2562177 | serdexmethylphenidate chloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2562180 | dexmethylphenidate / serdexmethylphenidate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2562180 | dexmethylphenidate / serdexmethylphenidate Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2562180 | dexmethylphenidate / serdexmethylphenidate Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2562181 | dexmethylphenidate / serdexmethylphenidate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2562183 | lidocaine HCl 2.8 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2562183 | lidocaine HCl 2.8 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2562183 | lidocaine HCl 2.8 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2562184 | dexmethylphenidate 5.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2562185 | serdexmethylphenidate 52.3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2562186 | Azstarys 5.2 MG / 26.1 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2562186 | Azstarys 5.2 MG / 26.1 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2562186 | Azstarys 5.2 MG / 26.1 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2562187 | dexmethylphenidate 5.2 MG / serdexmethylphenidate 26.1 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2562187 | dexmethylphenidate 5.2 MG / serdexmethylphenidate 26.1 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2562187 | dexmethylphenidate 5.2 MG / serdexmethylphenidate 26.1 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2562188 | dexmethylphenidate 10.4 MG / serdexmethylphenidate 52.3 MG [Azstarys] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2562189 | dexmethylphenidate / serdexmethylphenidate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2562190 | dexmethylphenidate 5.2 MG / serdexmethylphenidate 26.1 MG [Azstarys] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2562191 | dexmethylphenidate 7.8 MG / serdexmethylphenidate 39.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2562191 | dexmethylphenidate 7.8 MG / serdexmethylphenidate 39.2 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2562191 | dexmethylphenidate 7.8 MG / serdexmethylphenidate 39.2 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2562192 | dexmethylphenidate / serdexmethylphenidate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2562192 | dexmethylphenidate / serdexmethylphenidate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2562192 | dexmethylphenidate / serdexmethylphenidate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2562193 | dexmethylphenidate 10.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2562194 | dexmethylphenidate 10.4 MG / serdexmethylphenidate 52.3 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2562194 | dexmethylphenidate 10.4 MG / serdexmethylphenidate 52.3 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2562194 | dexmethylphenidate 10.4 MG / serdexmethylphenidate 52.3 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2562195 | dexmethylphenidate 7.8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2562196 | dexmethylphenidate 7.8 MG / serdexmethylphenidate 39.2 MG [Azstarys] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2562197 | serdexmethylphenidate 39.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2562198 | dexmethylphenidate / serdexmethylphenidate Oral Capsule [Azstarys] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2562199 | Azstarys 10.4 MG / 52.3 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2562199 | Azstarys 10.4 MG / 52.3 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2562199 | Azstarys 10.4 MG / 52.3 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2562200 | Azstarys Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2562201 | serdexmethylphenidate 26.1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2562202 | Azstarys | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2562203 | Azstarys Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2562204 | Azstarys 7.8 MG / 39.2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2562204 | Azstarys 7.8 MG / 39.2 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2562204 | Azstarys 7.8 MG / 39.2 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2562541 | calcium gluconate 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2562542 | calcium gluconate 1000 MG in 100 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2562542 | calcium gluconate 1000 MG in 100 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2562542 | calcium gluconate 1000 MG in 100 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2562543 | calcium gluconate 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2562544 | .beta.-eudesmol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2562545 | corynoxeine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2562546 | honokiol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2562547 | isocorynoxeine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2562548 | isorhynchophylline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2562549 | magnolol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2562550 | oxypaeoniflora | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2562551 | proximadiol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2562552 | rhynchophylline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2562553 | influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2562554 | influenza A virus A/Washington/19/2020 (H1N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2562555 | influenza A virus A/Wisconsin/588/2019 (H1N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2562680 | Cordia boissieri whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2562811 | finerenone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2562811 | finerenone | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2562811 | finerenone | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2562811 | finerenone | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2562811 | finerenone | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2562812 | finerenone 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2562813 | finerenone Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2562813 | finerenone Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2562813 | finerenone Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2562814 | finerenone Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2562815 | finerenone Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2562816 | finerenone 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2562816 | finerenone 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2562816 | finerenone 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2562816 | finerenone 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2562817 | Kerendia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2562818 | finerenone 10 MG [Kerendia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2562819 | finerenone Oral Tablet [Kerendia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2562820 | Kerendia Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2562821 | Kerendia Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2562822 | Kerendia 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2562822 | Kerendia 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2562822 | Kerendia 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2562823 | finerenone 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2562824 | finerenone 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2562824 | finerenone 20 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2562824 | finerenone 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2562824 | finerenone 20 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2562825 | finerenone 20 MG [Kerendia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2562826 | Kerendia 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2562826 | Kerendia 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2562826 | Kerendia 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2562883 | direct yellow 6 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2562886 | dimethicone 2 % / zinc oxide 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2562886 | dimethicone 2 % / zinc oxide 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2562886 | dimethicone 2 % / zinc oxide 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2562886 | dimethicone 2 % / zinc oxide 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2562993 | influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2562995 | FLUCELVAX Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2562995 | FLUCELVAX Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2562995 | FLUCELVAX Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2562996 | FLUAD Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2562996 | FLUAD Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2562996 | FLUAD Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2562997 | influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2562997 | influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2562997 | influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2562998 | influenza virus vaccine 2021-2022 (quadrivalent Cambodia/Victoria/Phuket/Victoria) 0.5 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2562998 | influenza virus vaccine 2021-2022 (quadrivalent Cambodia/Victoria/Phuket/Victoria) 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2562998 | influenza virus vaccine 2021-2022 (quadrivalent Cambodia/Victoria/Phuket/Victoria) 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563000 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML [Fluzone Quadrivalent 2021-2022] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2563001 | influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2563002 | FLUBOK Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2563002 | FLUBOK Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563002 | FLUBOK Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2563004 | Fluzone Quadrivalent 2021-2022 high dose vaccine 0.7 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2563004 | Fluzone Quadrivalent 2021-2022 high dose vaccine 0.7 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2563004 | Fluzone Quadrivalent 2021-2022 high dose vaccine 0.7 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563005 | influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Fluad Quadrivalent 2021-2022] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2563006 | influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Fluad Quadrivalent 2021-2022] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2563007 | influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2563007 | influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2563007 | influenza virus vaccine 2021-2022 (quadrivalent Tasmania/Washington/Darwin/Singapore) 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563008 | Flucelvax Quadrivalent 2021-2022 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2563009 | influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2563009 | influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2563009 | influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563010 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.0857 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2563011 | influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2563012 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2563013 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021-2022] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2563014 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection [Fluzone Quadrivalent 2021-2022] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2563015 | influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2563016 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2563017 | influenza virus vaccine 2021-2022 high-dose (quadrivalent - Phuket/Tasmania/Victoria/Washington) 0.7 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2563017 | influenza virus vaccine 2021-2022 high-dose (quadrivalent - Phuket/Tasmania/Victoria/Washington) 0.7 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2563017 | influenza virus vaccine 2021-2022 high-dose (quadrivalent - Phuket/Tasmania/Victoria/Washington) 0.7 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563018 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2563019 | Flublok Quadrivalent 2021-2022 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2563020 | FLUCELVAX Quadrivalent 2021-2022 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2563020 | FLUCELVAX Quadrivalent 2021-2022 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563020 | FLUCELVAX Quadrivalent 2021-2022 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2563021 | Flucelvax Quadrivalent 2021-2022 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2563022 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML [Flucelvax Quadrivalent 2021-2022] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2563023 | influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2563024 | influenza virus vaccine 2021-2022 (quadrivalent generic for Flublok - Phuket/Tasmania/Washington/Wisconsin) 0.5 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2563024 | influenza virus vaccine 2021-2022 (quadrivalent generic for Flublok - Phuket/Tasmania/Washington/Wisconsin) 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2563024 | influenza virus vaccine 2021-2022 (quadrivalent generic for Flublok - Phuket/Tasmania/Washington/Wisconsin) 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563025 | Fluzone Quadrivalent 2021-2022 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2563028 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2563029 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Washington/19/2020 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Darwin/7/2019 antigen 0.03 MG/ML / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen 0.03 MG/ML Prefilled Syringe [Flucelvax Quadrivalent 2021-2022] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2563031 | Fluzone Quadrivalent 2021-2022 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2563031 | Fluzone Quadrivalent 2021-2022 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563031 | Fluzone Quadrivalent 2021-2022 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2563032 | Fluzone Quadrivalent 2021-2022 vaccine 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2563032 | Fluzone Quadrivalent 2021-2022 vaccine 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2563032 | Fluzone Quadrivalent 2021-2022 vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563033 | Fluad Quadrivalent 2021-2022 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2563034 | Fluad Quadrivalent 2021-2022 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2563035 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.03 MG/ML Prefilled Syringe [Fluzone Quadrivalent 2021-2022] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2563036 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.09 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2563037 | Flublok Quadrivalent 2021-2022 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2563038 | Fluzone Quadrivalent 2021-2022 vaccine 0.25 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2563038 | Fluzone Quadrivalent 2021-2022 vaccine 0.25 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2563038 | Fluzone Quadrivalent 2021-2022 vaccine 0.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563039 | Fluzone Quadrivalent 2021-2022 vaccine 0.5 Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2563039 | Fluzone Quadrivalent 2021-2022 vaccine 0.5 Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2563039 | Fluzone Quadrivalent 2021-2022 vaccine 0.5 Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563042 | Fluzone Quadrivalent 2021-2022 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2563043 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML Prefilled Syringe [Flublok Quadrivalent 2021-2022] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2563044 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Wisconsin/588/2019 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.09 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.09 MG/ML [Flublok Quadrivalent 2021-2022] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2563046 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 0.0857 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.0857 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.0857 MG/ML / influenza B virus B/Washington/02/2019 antigen 0.0857 MG/ML [Fluzone Quadrivalent 2021-2022] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2563047 | influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) 0.5 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2563047 | influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) 0.5 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2563047 | influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) 0.5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563048 | influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) 0.25 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2563048 | influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) 0.25 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2563048 | influenza virus vaccine 2021-2022 (quadrivalent - Phuket/Tasmania/Victoria/Washington) 0.25 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563143 | direct blue 1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2563144 | Canavalia gladiata seed pod extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2563298 | cholecalciferol Wafer Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2563299 | cholecalciferol Oral Wafer | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2563300 | cholecalciferol 1.25 MG Oral Wafer | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563300 | cholecalciferol 1.25 MG Oral Wafer | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2563300 | cholecalciferol 1.25 MG Oral Wafer | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563300 | cholecalciferol 1.25 MG Oral Wafer | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563301 | cholecalciferol 0.35 MG Oral Wafer | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563301 | cholecalciferol 0.35 MG Oral Wafer | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2563301 | cholecalciferol 0.35 MG Oral Wafer | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563301 | cholecalciferol 0.35 MG Oral Wafer | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563379 | zinc oxide 110 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2563380 | zinc oxide 11 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2563380 | zinc oxide 11 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563380 | zinc oxide 11 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2563380 | zinc oxide 11 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563408 | menthol 16 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563408 | menthol 16 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563408 | menthol 16 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2563411 | bupivacaine 132 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2563411 | bupivacaine 132 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2563412 | BUPivacaine 660 MG in 5 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2563412 | BUPivacaine 660 MG in 5 mL Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2563412 | BUPivacaine 660 MG in 5 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563412 | BUPivacaine 660 MG in 5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563412 | BUPivacaine 660 MG in 5 mL Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2563413 | Posimir | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2563414 | bupivacaine 132 MG/ML [Posimir] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2563414 | bupivacaine 132 MG/ML [Posimir] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2563415 | bupivacaine Injection [Posimir] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2563415 | bupivacaine Injection [Posimir] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2563416 | Posimir Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2563417 | Posimir 660 MG in 5 mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2563417 | Posimir 660 MG in 5 mL Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 2563417 | Posimir 660 MG in 5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563417 | Posimir 660 MG in 5 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563417 | Posimir 660 MG in 5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563418 | bupivacaine 132 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2563418 | bupivacaine 132 MG/ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2563419 | bupivacaine 132 MG/ML Injection [Posimir] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2563419 | bupivacaine 132 MG/ML Injection [Posimir] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2563419 | bupivacaine 132 MG/ML Injection [Posimir] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2563423 | Vazalore | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2563424 | aspirin 325 MG [Vazalore] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2563425 | aspirin Oral Capsule [Vazalore] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2563426 | Vazalore Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2563427 | Vazalore Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2563428 | Vazalore 325 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563428 | Vazalore 325 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2563428 | Vazalore 325 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563428 | Vazalore 325 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563430 | aspirin 81 MG [Vazalore] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2563431 | Vazalore 81 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563431 | Vazalore 81 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2563431 | Vazalore 81 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563431 | Vazalore 81 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563588 | pectin 10.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2563589 | pectin 10.5 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2563589 | pectin 10.5 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2563599 | cholecalciferol / menatetrenone Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2563600 | cholecalciferol 25 MCG / menatetrenone 100 MCG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2563600 | cholecalciferol 25 MCG / menatetrenone 100 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563600 | cholecalciferol 25 MCG / menatetrenone 100 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563622 | Monarda didyma leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2563625 | yeast, beta-D-glucan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2563676 | acid blue 80 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2563680 | folic acid 0.4 MG / vitamin B12 2.5 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563680 | folic acid 0.4 MG / vitamin B12 2.5 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563680 | folic acid 0.4 MG / vitamin B12 2.5 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2563680 | folic acid 0.4 MG / vitamin B12 2.5 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563845 | Air | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2563845 | Air | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 25639 | Pepsin C | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 25639 | Pepsin C | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2563920 | Eryngium maritimum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2563966 | odevixibat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2563966 | odevixibat | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2563966 | odevixibat | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2563966 | odevixibat | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2563966 | odevixibat | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2563969 | insulin glargine-yfgn | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2563970 | insulin glargine-yfgn 100 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2563971 | insulin glargine-yfgn 300 UNT in 3 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2563971 | insulin glargine-yfgn 300 UNT in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563971 | insulin glargine-yfgn 300 UNT in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563971 | insulin glargine-yfgn 300 UNT in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563972 | insulin glargine-yfgn 100 UNT/ML [Semglee] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2563973 | Semglee (insulin glargine-yfgn) 300 UNT in 3 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2563973 | Semglee (insulin glargine-yfgn) 300 UNT in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563973 | Semglee (insulin glargine-yfgn) 300 UNT in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563973 | Semglee (insulin glargine-yfgn) 300 UNT in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563974 | insulin glargine-yfgn 100 UNT/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2563975 | insulin glargine-yfgn 100 UNT/ML Pen Injector [Semglee] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2563976 | insulin glargine-yfgn 100 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563976 | insulin glargine-yfgn 100 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2563977 | Semglee (insulin glargine-yfgn) 100 UNT/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2563977 | Semglee (insulin glargine-yfgn) 100 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563977 | Semglee (insulin glargine-yfgn) 100 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563978 | odevixibat sesquihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2563979 | odevixibat 0.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2563980 | odevixibat Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2563980 | odevixibat Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2563980 | odevixibat Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2563981 | odevixibat Pellet Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2563982 | odevixibat Oral Pellet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2563983 | odevixibat 200 MCG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563983 | odevixibat 200 MCG Oral Pellet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2563983 | odevixibat 200 MCG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563983 | odevixibat 200 MCG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563983 | odevixibat 200 MCG Oral Pellet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2563983 | odevixibat 200 MCG Oral Pellet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2563984 | Bylvay | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2563985 | odevixibat 0.2 MG [Bylvay] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2563986 | odevixibat Oral Pellet [Bylvay] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2563987 | Bylvay Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2563988 | Bylvay Pellet Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2563989 | Bylvay 200 MCG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563989 | Bylvay 200 MCG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563989 | Bylvay 200 MCG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563989 | Bylvay 200 MCG Oral Pellet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2563990 | odevixibat 0.6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2563991 | odevixibat 600 MCG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563991 | odevixibat 600 MCG Oral Pellet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2563991 | odevixibat 600 MCG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563991 | odevixibat 600 MCG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563991 | odevixibat 600 MCG Oral Pellet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2563991 | odevixibat 600 MCG Oral Pellet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2563992 | odevixibat 0.6 MG [Bylvay] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2563993 | Bylvay 600 MCG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563993 | Bylvay 600 MCG Oral Pellet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563993 | Bylvay 600 MCG Oral Pellet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563993 | Bylvay 600 MCG Oral Pellet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2563994 | odevixibat 0.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2563995 | odevixibat Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2563996 | odevixibat Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2563997 | odevixibat 400 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563997 | odevixibat 400 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2563997 | odevixibat 400 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2563997 | odevixibat 400 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2563997 | odevixibat 400 MCG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2563997 | odevixibat 400 MCG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2563998 | odevixibat 0.4 MG [Bylvay] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2563999 | odevixibat Oral Capsule [Bylvay] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2564000 | Bylvay Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2564001 | Bylvay 400 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2564001 | Bylvay 400 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2564001 | Bylvay 400 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2564001 | Bylvay 400 MCG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2564002 | odevixibat 1.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2564003 | odevixibat 1200 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2564003 | odevixibat 1200 MCG Oral Capsule | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2564003 | odevixibat 1200 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2564003 | odevixibat 1200 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2564003 | odevixibat 1200 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2564003 | odevixibat 1200 MCG Oral Capsule | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2564004 | odevixibat 1.2 MG [Bylvay] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2564005 | Bylvay 1200 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2564005 | Bylvay 1200 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2564005 | Bylvay 1200 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2564005 | Bylvay 1200 MCG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2564006 | Petasites amplus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2564013 | diphenhydramine / pramoxine Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2564013 | diphenhydramine / pramoxine Shampoo Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2564014 | diphenhydramine / pramoxine Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2564014 | diphenhydramine / pramoxine Medicated Shampoo | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2564015 | diphenhydrAMINE HCl 1 % / pramoxine HCl 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2564015 | diphenhydrAMINE HCl 1 % / pramoxine HCl 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2564015 | diphenhydrAMINE HCl 1 % / pramoxine HCl 1 % Medicated Shampoo | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2564015 | diphenhydrAMINE HCl 1 % / pramoxine HCl 1 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2564015 | diphenhydrAMINE HCl 1 % / pramoxine HCl 1 % Medicated Shampoo | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2564017 | Afluria Quadrivalent 2021-2022 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2564018 | influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML [Afluria Quadrivalent 2021-2022] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2564020 | Afluria Quadrivalent 2021-2022 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2564021 | afluria Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2564021 | afluria Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2564021 | afluria Quadrivalent 2021-2022 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2564022 | influenza A virus A/Cambodia/e0826360/2020 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Victoria/2570/2019 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML / influenza B virus B/Victoria/705/2018 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2021-2022] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2564023 | influenza virus vaccine 2021-2022 (quadrivalent Cambodia/Victoria/Phuket/Victoria) 0.25 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2564023 | influenza virus vaccine 2021-2022 (quadrivalent Cambodia/Victoria/Phuket/Victoria) 0.25 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2564023 | influenza virus vaccine 2021-2022 (quadrivalent Cambodia/Victoria/Phuket/Victoria) 0.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2564024 | afluria Quadrivalent 2021-2022 vaccine 0.25 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2564024 | afluria Quadrivalent 2021-2022 vaccine 0.25 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2564024 | afluria Quadrivalent 2021-2022 vaccine 0.25 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2564025 | belumosudil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2564025 | belumosudil | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2564025 | belumosudil | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2564025 | belumosudil | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2564025 | belumosudil | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2564026 | antimony sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2564027 | belumosudil 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2564028 | belumosudil Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2564028 | belumosudil Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2564028 | belumosudil Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2564029 | belumosudil Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2564030 | belumosudil Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2564031 | belumosudil 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2564031 | belumosudil 200 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2564031 | belumosudil 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2564031 | belumosudil 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2564031 | belumosudil 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2564031 | belumosudil 200 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2564032 | Rezurock | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2564033 | belumosudil 200 MG [Rezurock] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2564034 | belumosudil Oral Tablet [Rezurock] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2564035 | Rezurock Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2564036 | Rezurock Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2564037 | REZUROCK 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2564037 | REZUROCK 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2564037 | REZUROCK 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2564037 | REZUROCK 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2564038 | afluria Quadrivalent 2021-2022 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2564038 | afluria Quadrivalent 2021-2022 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2564038 | afluria Quadrivalent 2021-2022 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2564040 | influenza virus vaccine 2021-2022 (quadrivalent Cambodia/Victoria/Phuket/Victoria) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2564040 | influenza virus vaccine 2021-2022 (quadrivalent Cambodia/Victoria/Phuket/Victoria) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2564040 | influenza virus vaccine 2021-2022 (quadrivalent Cambodia/Victoria/Phuket/Victoria) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2564146 | Fexinidazole | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2564146 | Fexinidazole | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2564146 | Fexinidazole | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2564146 | Fexinidazole | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2564146 | Fexinidazole | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2564147 | fexinidazole 600 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2564148 | fexinidazole Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2564148 | fexinidazole Oral Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2564148 | fexinidazole Oral Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2564149 | fexinidazole Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2564150 | fexinidazole Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2564151 | fexinidazole 600 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2564151 | fexinidazole 600 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2564151 | fexinidazole 600 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2564151 | fexinidazole 600 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2564152 | fexinidazole 600 MG Tablet 10-Day Dose Pack (35 KG+) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2564152 | fexinidazole 600 MG Tablet 10-Day Dose Pack (35 KG+) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2564152 | fexinidazole 600 MG Tablet 10-Day Dose Pack (35 KG+) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2564153 | fexinidazole 600 MG Tablet 10-Day Dose Pack (20 KG - < 35 KG) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2564153 | fexinidazole 600 MG Tablet 10-Day Dose Pack (20 KG - < 35 KG) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2564153 | fexinidazole 600 MG Tablet 10-Day Dose Pack (20 KG - < 35 KG) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 25643 | Gastrin I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 25643 | Gastrin I | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 25643 | Gastrin I | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 25643 | Gastrin I | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2564382 | Jasminum officinale fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2564388 | menthol 0.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2564388 | menthol 0.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2564388 | menthol 0.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2564394 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2564395 | influenza A virus A/Victoria/1/2020 (H1N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2564396 | influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 25644 | Gastrin-releasing peptide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 25644 | Gastrin-releasing peptide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2564400 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2564401 | FluMist Quadrivalent 2021-2022 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2564402 | influenza A virus A/Tasmania/503/2020 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Victoria/1/2020 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML / influenza B virus B/Washington/02/2019 antigen 158000000 UNT/ML [FluMist Quadrivalent 2021-2022] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2564403 | FluMist Quadrivalent 2021-2022 Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2564404 | FluMist Quadrivalent 2021-2022 Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2564406 | FluMist Quadrivalent, 2021-2022 Formula Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2564406 | FluMist Quadrivalent, 2021-2022 Formula Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2564406 | FluMist Quadrivalent, 2021-2022 Formula Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2564407 | amylase 149900 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2564408 | lipase 37000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2564409 | protease 97300 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2564410 | amylase 149,900 UNT / lipase 37,000 UNT / protease 97,300 UNT Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2564410 | amylase 149,900 UNT / lipase 37,000 UNT / protease 97,300 UNT Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2564411 | amylase 149900 UNT / lipase 37000 UNT / protease 97300 UNT [Pancreaze] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2564412 | PANCREAZE 37,000 UNT / 149,900 UNT / 97,300 UNT Delayed Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2564412 | PANCREAZE 37,000 UNT / 149,900 UNT / 97,300 UNT Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2564412 | PANCREAZE 37,000 UNT / 149,900 UNT / 97,300 UNT Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2564413 | steardimonium hydroxypropyl peg-7 dimethicone phosphate chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2565 | Citrinin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565 | Citrinin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565262 | benzalkonium chloride 0.00066 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2565263 | benzalkonium chloride 0.066 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2565263 | benzalkonium chloride 0.066 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2565263 | benzalkonium chloride 0.066 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2565264 | .beta.-cyclodextrin sulfobutyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2565265 | anifrolumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2565266 | ethenyl | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2565267 | glucose 1,6-bisphosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2565268 | selexipag 1.8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2565269 | selexipag Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2565270 | selexipag Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2565271 | selexipag 1800 MCG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2565271 | selexipag 1800 MCG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2565272 | selexipag 1.8 MG [Uptravi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2565273 | Uptravi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2565274 | selexipag Injection [Uptravi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2565275 | Uptravi 1800 MCG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2565275 | Uptravi 1800 MCG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2565275 | Uptravi 1800 MCG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2565275 | Uptravi 1800 MCG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2565276 | anifrolumab-fnia | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2565277 | anifrolumab-fnia 150 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2565278 | anifrolumab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2565279 | anifrolumab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2565280 | anifrolumab-fnia 300 MG per 2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2565280 | anifrolumab-fnia 300 MG per 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2565280 | anifrolumab-fnia 300 MG per 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2565281 | anifrolumab-fnia 150 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2565281 | anifrolumab-fnia 150 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2565282 | Saphnelo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2565283 | anifrolumab-fnia 150 MG/ML [Saphnelo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2565284 | Saphnelo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2565285 | anifrolumab Injection [Saphnelo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2565286 | Saphnelo 300 MG in 2 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2565286 | Saphnelo 300 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2565286 | Saphnelo 300 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2565286 | Saphnelo 300 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2565287 | Saphnelo 150 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2565287 | Saphnelo 150 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2565287 | Saphnelo 150 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2565422 | benzalkonium chloride 0.75 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2565423 | benzalkonium chloride 0.075 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2565423 | benzalkonium chloride 0.075 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2565487 | polyurethane-62 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2565488 | iota-carrageenan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2565490 | ethanol 78.5 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2565490 | ethanol 78.5 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2565490 | ethanol 78.5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2565491 | aspirin 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2565491 | aspirin 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2565491 | aspirin 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2565492 | 1 daytime (aspirin 325 MG / dextromethorphan HBr 10 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet) / 1 nighttime (aspirin 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| Concept ID (RxCUI): 2565492 | 1 daytime (aspirin 325 MG / dextromethorphan HBr 10 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet) / 1 nighttime (aspirin 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2565492 | 1 daytime (aspirin 325 MG / dextromethorphan HBr 10 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet) / 1 nighttime (aspirin 325 MG / dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 25655 | Gaviscon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2565686 | carboxymethylcellulose sodium (1.3 carboxymethyl substitution per saccharide; 600 MPA.S at 2%) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2565687 | Leonurus japonicus stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2565688 | Pyrus communis flower whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2565689 | Rhinacanthus nasutus whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2565690 | Ziziphus jujuba var. spinosa seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2565692 | Belumosudil mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2565692 | Belumosudil mesilate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565692 | Belumosudil mesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 2565692 | Belumosudil mesilate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565804 | benzoyl peroxide / tretinoin | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2565805 | benzoyl peroxide / tretinoin Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2565806 | benzoyl peroxide / tretinoin Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2565807 | benzoyl peroxide 3 % / tretinoin 0.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2565807 | benzoyl peroxide 3 % / tretinoin 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2565807 | benzoyl peroxide 3 % / tretinoin 0.1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2565808 | Twyneo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2565809 | benzoyl peroxide 30 MG/ML / tretinoin 1 MG/ML [Twyneo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2565810 | Twyneo Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2565811 | benzoyl peroxide / tretinoin Topical Cream [Twyneo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2565812 | Twyneo 3 % / 0.1 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2565812 | Twyneo 3 % / 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2565812 | Twyneo 3 % / 0.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2565813 | avalglucosidase alfa-ngpt | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 2565814 | avalglucosidase alfa | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2565814 | avalglucosidase alfa | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2565814 | avalglucosidase alfa | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2565814 | avalglucosidase alfa | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2565814 | avalglucosidase alfa | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2565815 | avalglucosidase alfa-ngpt 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2565816 | avalglucosidase alfa Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2565816 | avalglucosidase alfa Injectable Product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2565816 | avalglucosidase alfa Injectable Product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2565817 | avalglucosidase alfa Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2565818 | avalglucosidase alfa-ngpt 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2565818 | avalglucosidase alfa-ngpt 100 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2565819 | Nexviazyme | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2565820 | avalglucosidase alfa-ngpt 100 MG [Nexviazyme] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2565821 | Nexviazyme Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2565822 | avalglucosidase alfa Injection [Nexviazyme] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2565823 | Nexviazyme 100 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2565823 | Nexviazyme 100 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2565823 | Nexviazyme 100 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2565921 | lidocaine 2 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2565921 | lidocaine 2 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2565921 | lidocaine 2 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2565925 | Imidazolidinone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2565925 | Imidazolidinone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565925 | Imidazolidinone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565925 | Imidazolidinone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565925 | Imidazolidinone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565926 | sodium caprylyl sulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2565947 | Lythrum salicaria whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2565948 | onion juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2565949 | Rosa chinensis flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2565950 | Loncastuximab tesirine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565950 | Loncastuximab tesirine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565951 | Loncastuximab tesirine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565951 | Loncastuximab tesirine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565952 | Lumasiran only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565952 | Lumasiran only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565953 | Lumasiran only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565953 | Lumasiran only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565954 | Margetuximab only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565954 | Margetuximab only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565955 | Margetuximab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565955 | Margetuximab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565956 | Product containing only vericiguat (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565956 | Product containing only vericiguat (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565957 | Product containing only vericiguat in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565957 | Product containing only vericiguat in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565958 | Product containing only vibegron (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565958 | Product containing only vibegron (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565959 | Product containing only vibegron in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565959 | Product containing only vibegron in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565960 | Product containing only voclosporin (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565960 | Product containing only voclosporin (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565961 | Product containing only voclosporin in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565961 | Product containing only voclosporin in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565962 | Nalmefene only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565962 | Nalmefene only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565963 | Naxitamab only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565963 | Naxitamab only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565964 | Naxitamab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565964 | Naxitamab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565965 | Berotralstat only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565965 | Berotralstat only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565966 | Berotralstat only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565966 | Berotralstat only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565967 | Diphtheria and hepatitis B and pertussis and tetanus vaccine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565967 | Diphtheria and hepatitis B and pertussis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2565967 | Diphtheria and hepatitis B and pertussis and tetanus vaccine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565968 | Botulinum toxin type B only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565968 | Botulinum toxin type B only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565969 | Peppermint oil only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565969 | Peppermint oil only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565970 | Cabotegravir only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565970 | Cabotegravir only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565971 | Cabotegravir only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565971 | Cabotegravir only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565972 | Carbetocin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565972 | Carbetocin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565973 | Casirivimab and imdevimab only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565973 | Casirivimab and imdevimab only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565974 | Casirivimab and imdevimab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565974 | Casirivimab and imdevimab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565975 | Casirivimab only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565975 | Casirivimab only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565976 | Casirivimab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565976 | Casirivimab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565977 | Cetuximab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565977 | Cetuximab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565978 | Prazepam only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565978 | Prazepam only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565979 | Dapoxetine only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565979 | Dapoxetine only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565980 | Dapoxetine only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565980 | Dapoxetine only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565981 | Agalsidase alfa only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565981 | Agalsidase alfa only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565982 | Dexketoprofen only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565982 | Dexketoprofen only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565983 | Dostarlimab only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565983 | Dostarlimab only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565984 | Dostarlimab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565984 | Dostarlimab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565985 | Epoetin theta only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565985 | Epoetin theta only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565986 | Epoetin zeta only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565986 | Epoetin zeta only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565987 | Evinacumab only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565987 | Evinacumab only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565988 | Evinacumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565988 | Evinacumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565989 | Exenatide only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565989 | Exenatide only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565990 | Ferric carboxymaltose only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565990 | Ferric carboxymaltose only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565991 | Amlodipine and perindopril only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565991 | Amlodipine and perindopril only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565992 | Amlodipine and perindopril only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565992 | Amlodipine and perindopril only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565993 | Fosdenopterin only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565993 | Fosdenopterin only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565994 | Fosdenopterin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565994 | Fosdenopterin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565995 | Gadobenic acid only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565995 | Gadobenic acid only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565996 | Product containing only relugolix (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565996 | Product containing only relugolix (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565997 | Product containing only relugolix in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565997 | Product containing only relugolix in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565998 | Ansuvimab only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565998 | Ansuvimab only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2565999 | Ansuvimab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2565999 | Ansuvimab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566000 | Gadobutrol only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566000 | Gadobutrol only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566001 | Gadoxetic acid only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566001 | Gadoxetic acid only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566002 | Golimumab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566002 | Golimumab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566003 | Recombinant Varicella-zoster glycoprotein E vaccine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566003 | Recombinant Varicella-zoster glycoprotein E vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566003 | Recombinant Varicella-zoster glycoprotein E vaccine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566004 | Product containing only rilpivirine in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566004 | Product containing only rilpivirine in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566005 | Product containing only sennoside B in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566005 | Product containing only sennoside B in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566006 | Product containing only setmelanotide (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566006 | Product containing only setmelanotide (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566007 | Product containing only setmelanotide in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566007 | Product containing only setmelanotide in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566008 | Idebenone only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566008 | Idebenone only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566009 | Idecabtagene vicleucel only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566009 | Idecabtagene vicleucel only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566010 | Idecabtagene vicleucel only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566010 | Idecabtagene vicleucel only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566011 | Imdevimab only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566011 | Imdevimab only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566012 | Imdevimab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566012 | Imdevimab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566013 | Product containing only sotrovimab (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566013 | Product containing only sotrovimab (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566014 | Product containing only sotrovimab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566014 | Product containing only sotrovimab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566015 | Influenza A virus A/California/7/2009 (H1N1)-like virus strain split virion haemagglutinin antigen only vaccine product | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 2566015 | Influenza A virus A/California/7/2009 (H1N1)-like virus strain split virion haemagglutinin antigen only vaccine product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566015 | Influenza A virus A/California/7/2009 (H1N1)-like virus strain split virion haemagglutinin antigen only vaccine product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566016 | Influenza A virus A/Indonesia/05/2005 (H5N1)-like virus strain split virion haemagglutinin antigen only vaccine product | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 2566016 | Influenza A virus A/Indonesia/05/2005 (H5N1)-like virus strain split virion haemagglutinin antigen only vaccine product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566016 | Influenza A virus A/Indonesia/05/2005 (H5N1)-like virus strain split virion haemagglutinin antigen only vaccine product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566017 | Product containing only tepotinib (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566017 | Product containing only tepotinib (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566018 | Product containing only tepotinib in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566018 | Product containing only tepotinib in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566019 | Product containing only tirbanibulin (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566019 | Product containing only tirbanibulin (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566020 | Product containing only tirbanibulin in cutaneous dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566020 | Product containing only tirbanibulin in cutaneous dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566021 | Laronidase only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566021 | Laronidase only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566022 | Lisocabtagene maraleucel only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566022 | Lisocabtagene maraleucel only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566023 | Lisocabtagene maraleucel only product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566023 | Lisocabtagene maraleucel only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566024 | Lonafarnib only product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566024 | Lonafarnib only product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566025 | Lonafarnib only product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566025 | Lonafarnib only product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566026 | Product containing only trilaciclib (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566026 | Product containing only trilaciclib (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566027 | Product containing only trilaciclib in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566027 | Product containing only trilaciclib in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566028 | Product containing only trimetazidine (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566028 | Product containing only trimetazidine (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566029 | Product containing only trimetazidine in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566029 | Product containing only trimetazidine in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566030 | Product containing only umbralisib (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566030 | Product containing only umbralisib (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566031 | Product containing only umbralisib in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566031 | Product containing only umbralisib in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566032 | Diphtheria and acellular pertussis and Haemophilus influenzae type b and hepatitis B and inactivated poliomyelitis and tetanus vaccine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566032 | Diphtheria and acellular pertussis and Haemophilus influenzae type b and hepatitis B and inactivated poliomyelitis and tetanus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566032 | Diphtheria and acellular pertussis and Haemophilus influenzae type b and hepatitis B and inactivated poliomyelitis and tetanus vaccine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566033 | Diphtheria toxoid, acellular pertussis, Haemophilus influenzae type b conjugated, hepatitis B, inactivated poliomyelitis and tetanus toxoid pediatric vaccine | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 2566033 | Diphtheria toxoid, acellular pertussis, Haemophilus influenzae type b conjugated, hepatitis B, inactivated poliomyelitis and tetanus toxoid pediatric vaccine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566033 | Diphtheria toxoid, acellular pertussis, Haemophilus influenzae type b conjugated, hepatitis B, inactivated poliomyelitis and tetanus toxoid pediatric vaccine | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566033 | Diphtheria toxoid, acellular pertussis, Haemophilus influenzae type b conjugated, hepatitis B, inactivated poliomyelitis and tetanus toxoid pediatric vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566033 | Diphtheria toxoid, acellular pertussis, Haemophilus influenzae type b conjugated, hepatitis B, inactivated poliomyelitis and tetanus toxoid pediatric vaccine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566034 | COVID-19 recombinant spike protein antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566034 | COVID-19 recombinant spike protein antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566034 | COVID-19 recombinant spike protein antigen vaccine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566034 | COVID-19 recombinant spike protein antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566034 | COVID-19 recombinant spike protein antigen vaccine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566035 | SARS-CoV-2 protein antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566035 | SARS-CoV-2 protein antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566035 | SARS-CoV-2 protein antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566035 | SARS-CoV-2 protein antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566035 | SARS-CoV-2 protein antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566035 | SARS-CoV-2 protein antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566036 | SARS-CoV-2 recombinant spike protein antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566036 | SARS-CoV-2 recombinant spike protein antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566036 | SARS-CoV-2 recombinant spike protein antigen | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566036 | SARS-CoV-2 recombinant spike protein antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566036 | SARS-CoV-2 recombinant spike protein antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566036 | SARS-CoV-2 recombinant spike protein antigen | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566037 | eugenol 0.04 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2566038 | camphor 4 % / eugenol 4 % / menthol 4 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566038 | camphor 4 % / eugenol 4 % / menthol 4 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566038 | camphor 4 % / eugenol 4 % / menthol 4 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566039 | camphor 0.08 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2566040 | eugenol 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2566041 | camphor / Eucalyptus oil / eugenol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2566042 | camphor / Eucalyptus oil / eugenol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2566043 | camphor / Eucalyptus oil / eugenol Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2566044 | camphor 8 % / eucalyptus oil 5 % / eugenol 2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566044 | camphor 8 % / eucalyptus oil 5 % / eugenol 2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566044 | camphor 8 % / eucalyptus oil 5 % / eugenol 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566088 | Clopidogrel (as clopidogrel besilate) 75 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566088 | Clopidogrel (as clopidogrel besilate) 75 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566088 | Clopidogrel (as clopidogrel besilate) 75 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566089 | Clopidogrel (as clopidogrel hydrochloride) 75 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566089 | Clopidogrel (as clopidogrel hydrochloride) 75 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566090 | Amlodipine (as amlodipine besilate) 10 mg and perindopril arginine 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566090 | Amlodipine (as amlodipine besilate) 10 mg and perindopril arginine 10 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566090 | Amlodipine (as amlodipine besilate) 10 mg and perindopril arginine 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566091 | Amlodipine (as amlodipine besilate) 10 mg and perindopril arginine 5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566091 | Amlodipine (as amlodipine besilate) 10 mg and perindopril arginine 5 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566091 | Amlodipine (as amlodipine besilate) 10 mg and perindopril arginine 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566092 | Amlodipine (as amlodipine besilate) 5 mg and perindopril arginine 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566092 | Amlodipine (as amlodipine besilate) 5 mg and perindopril arginine 10 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566092 | Amlodipine (as amlodipine besilate) 5 mg and perindopril arginine 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566093 | Amlodipine (as amlodipine besilate) 5 mg and perindopril arginine 5 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566093 | Amlodipine (as amlodipine besilate) 5 mg and perindopril arginine 5 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566093 | Amlodipine (as amlodipine besilate) 5 mg and perindopril arginine 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566094 | Cefaclor 375 mg prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566094 | Cefaclor 375 mg prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566095 | Colecalciferol 20 microgram oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566095 | Colecalciferol 20 microgram oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566095 | Colecalciferol 20 microgram oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566096 | Colecalciferol 500 microgram oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566096 | Colecalciferol 500 microgram oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566096 | Colecalciferol 500 microgram oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566097 | Citalopram (as citalopram hydrobromide) 30 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566097 | Citalopram (as citalopram hydrobromide) 30 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566098 | Conjugated estrogen 300 microgram and medroxyprogesterone acetate 1.5 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566098 | Conjugated estrogen 300 microgram and medroxyprogesterone acetate 1.5 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566099 | Conjugated estrogen 450 microgram and medroxyprogesterone acetate 1.5 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566099 | Conjugated estrogen 450 microgram and medroxyprogesterone acetate 1.5 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566100 | Conjugated estrogen 625 microgram and medroxyprogesterone acetate 2.5 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566100 | Conjugated estrogen 625 microgram and medroxyprogesterone acetate 2.5 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566101 | Dapoxetine (as dapoxetine hydrochloride) 30 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566101 | Dapoxetine (as dapoxetine hydrochloride) 30 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566102 | Dapoxetine (as dapoxetine hydrochloride) 60 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566102 | Dapoxetine (as dapoxetine hydrochloride) 60 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566104 | Darunavir (as darunavir propylene glycolate) 800 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566104 | Darunavir (as darunavir propylene glycolate) 800 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566105 | Dimethyl fumarate 120 mg gastro-resistant oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566105 | Dimethyl fumarate 120 mg gastro-resistant oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566106 | Dimethyl fumarate 30 mg gastro-resistant oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566106 | Dimethyl fumarate 30 mg gastro-resistant oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566107 | Doxycycline 100 mg orodispersible tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566107 | Doxycycline 100 mg orodispersible tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566108 | Febuxostat 120 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566108 | Febuxostat 120 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566109 | Idebenone 150 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566109 | Idebenone 150 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566110 | Ivabradine (as ivabradine oxalate) 5 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566110 | Ivabradine (as ivabradine oxalate) 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566111 | Ivabradine (as ivabradine oxalate) 7.5 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566111 | Ivabradine (as ivabradine oxalate) 7.5 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566112 | Nalmefene (as nalmefene hydrochloride) 18 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566112 | Nalmefene (as nalmefene hydrochloride) 18 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566113 | Phenoxymethylpenicillin (as phenoxymethylpenicillin calcium) 300 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566113 | Phenoxymethylpenicillin (as phenoxymethylpenicillin calcium) 300 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566113 | Phenoxymethylpenicillin (as phenoxymethylpenicillin calcium) 300 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566114 | Phenoxymethylpenicillin (as phenoxymethylpenicillin calcium) 600 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566114 | Phenoxymethylpenicillin (as phenoxymethylpenicillin calcium) 600 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566114 | Phenoxymethylpenicillin (as phenoxymethylpenicillin calcium) 600 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566115 | Perindopril arginine 10 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566115 | Perindopril arginine 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566116 | Prasugrel (as prasugrel besilate) 10 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566116 | Prasugrel (as prasugrel besilate) 10 mg oral tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566116 | Prasugrel (as prasugrel besilate) 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566117 | Product containing precisely rasagiline (as rasagiline tartrate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566117 | Product containing precisely rasagiline (as rasagiline tartrate) 1 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566119 | Product containing precisely trientine (as trientine tetrahydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566119 | Product containing precisely trientine (as trientine tetrahydrochloride) 150 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566120 | Product containing precisely upadacitinib 15 milligram/1 each prolonged-release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566120 | Product containing precisely upadacitinib 15 milligram/1 each prolonged-release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566121 | Product containing precisely zinc (as zinc sulfate) 45 milligram/1 each conventional release effervescent oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566121 | Product containing precisely zinc (as zinc sulfate) 45 milligram/1 each conventional release effervescent oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566187 | bupivacaine liposome 13.3 MG/ML [Nocita] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2566187 | bupivacaine liposome 13.3 MG/ML [Nocita] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2566188 | Nocita Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2566189 | bupivacaine Injection [Nocita] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2566189 | bupivacaine Injection [Nocita] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2566190 | Nocita 13.3 MG/ML in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2566190 | Nocita 13.3 MG/ML in 10 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2566190 | Nocita 13.3 MG/ML in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566190 | Nocita 13.3 MG/ML in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566191 | bupivacaine liposome 13.3 MG/ML Injection [Nocita] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2566191 | bupivacaine liposome 13.3 MG/ML Injection [Nocita] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2566191 | bupivacaine liposome 13.3 MG/ML Injection [Nocita] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566191 | bupivacaine liposome 13.3 MG/ML Injection [Nocita] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566192 | dicapryl adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2566193 | Ceftazidime 250 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566193 | Ceftazidime 250 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566195 | Alprostadil 500 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566195 | Alprostadil 500 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566275 | C12-16 pareth-7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2566277 | Opuntia tuna fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2566287 | allyl amyl glycolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2566288 | triethoxysilylethyl polydimethylsiloxyethyl hexyl dimethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2566289 | benzocaine 12 % / lidocaine hydrochloride 5 % / tetracaine hydrochloride 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566289 | benzocaine 12 % / lidocaine hydrochloride 5 % / tetracaine hydrochloride 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566289 | benzocaine 12 % / lidocaine hydrochloride 5 % / tetracaine hydrochloride 1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566290 | benzocaine 12 % / lidocaine hydrochloride 5 % / tetracaine hydrochloride 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566290 | benzocaine 12 % / lidocaine hydrochloride 5 % / tetracaine hydrochloride 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566290 | benzocaine 12 % / lidocaine hydrochloride 5 % / tetracaine hydrochloride 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566291 | Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2566292 | Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2566293 | Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2566294 | Streptococcus pneumoniae serotype 15B capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2566295 | Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2566296 | Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2566297 | Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2566298 | Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566299 | Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566300 | Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566301 | Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566302 | Streptococcus pneumoniae serotype 15B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566303 | Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566304 | Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566305 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 15B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2566306 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 15B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2566307 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 15B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2566308 | pneumococcal 20-valent conjugate vaccine (PCV20) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2566308 | pneumococcal 20-valent conjugate vaccine (PCV20) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2566308 | pneumococcal 20-valent conjugate vaccine (PCV20) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2566309 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 15B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566310 | Prevnar 20 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2566311 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 15B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML [Prevnar 20] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2566312 | Prevnar 20 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2566313 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 15B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe [Prevnar 20] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2566314 | PREVNAR 20 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2566314 | PREVNAR 20 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2566314 | PREVNAR 20 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2566315 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 10A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 11A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 12F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 15B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0088 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 8 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.0044 MG/ML Prefilled Syringe [Prevnar 20] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2566405 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566406 | Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566407 | Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566408 | Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566409 | Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566410 | Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566411 | Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566412 | Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566413 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2566414 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2566415 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2566416 | pneumococcal 15-valent conjugate vaccine 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2566416 | pneumococcal 15-valent conjugate vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2566416 | pneumococcal 15-valent conjugate vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2566417 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566418 | Vaxneuvance | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2566419 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML [Vaxneuvance] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2566420 | Vaxneuvance Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2566421 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine Prefilled Syringe [Vaxneuvance] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2566422 | VAXNEUVANCE 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2566422 | VAXNEUVANCE 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2566422 | VAXNEUVANCE 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2566423 | Streptococcus pneumoniae serotype 1 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 18C capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 19F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 22F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 23F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 3 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 33F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 4 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 5 capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6A capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 6B capsular antigen diphtheria CRM197 protein conjugate vaccine 0.008 MG/ML / Streptococcus pneumoniae serotype 7F capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML / Streptococcus pneumoniae serotype 9V capsular antigen diphtheria CRM197 protein conjugate vaccine 0.004 MG/ML Prefilled Syringe [Vaxneuvance] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2566426 | Pemetrexed diarginine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566426 | Pemetrexed diarginine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566433 | Betacillin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2566434 | amoxicillin 100 MG / clavulanate 25 MG [Betacillin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2566435 | Betacillin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2566436 | Betacillin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2566437 | amoxicillin / clavulanate Oral Tablet [Betacillin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2566438 | Betacillin 100 MG / 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2566438 | Betacillin 100 MG / 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566438 | Betacillin 100 MG / 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566439 | TAYSOFY 1 MG / 20 MCG 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| Concept ID (RxCUI): 2566439 | TAYSOFY 1 MG / 20 MCG 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2566439 | TAYSOFY 1 MG / 20 MCG 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2566440 | amoxicillin 200 MG / clavulanate 50 MG [Betacillin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2566441 | Betacillin 200 MG / 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2566441 | Betacillin 200 MG / 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566441 | Betacillin 200 MG / 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566442 | amoxicillin 300 MG / clavulanate 75 MG [Betacillin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2566443 | Betacillin 300 MG / 75 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2566443 | Betacillin 300 MG / 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566443 | Betacillin 300 MG / 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566444 | amoxicillin 50 MG / clavulanate 12.5 MG [Betacillin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2566445 | Betacillin 50 MG / 12.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2566445 | Betacillin 50 MG / 12.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566445 | Betacillin 50 MG / 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566607 | levothyroxine sodium 0.0625 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566608 | levothyroxine sodium 62.5 MCG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2566608 | levothyroxine sodium 62.5 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2566609 | levothyroxine sodium 0.0625 MG/ML [Tirosint] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2566610 | TIROSINT - SOL 62.5 MCG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2566610 | TIROSINT - SOL 62.5 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2566610 | TIROSINT - SOL 62.5 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2566612 | levothyroxine sodium 0.0375 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566613 | levothyroxine sodium 37.5 MCG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2566613 | levothyroxine sodium 37.5 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2566614 | levothyroxine sodium 0.0375 MG/ML [Tirosint] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2566615 | TIROSINT - SOL 37.5 MCG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2566615 | TIROSINT - SOL 37.5 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2566615 | TIROSINT - SOL 37.5 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2566616 | levothyroxine sodium 0.044 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566617 | levothyroxine sodium 44 MCG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2566617 | levothyroxine sodium 44 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2566618 | levothyroxine sodium 0.044 MG/ML [Tirosint] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2566619 | TIROSINT - SOL 44 MCG in 1 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2566619 | TIROSINT - SOL 44 MCG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2566619 | TIROSINT - SOL 44 MCG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2566620 | solvent yellow 18 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2566787 | menthol 3.5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566787 | menthol 3.5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566787 | menthol 3.5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566788 | acetaminophen 325 MG per 5 mL / dextromethorphan 10 MG per 5 mL / phenylephrine hydrochloride 5 MG per 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566788 | acetaminophen 325 MG per 5 mL / dextromethorphan 10 MG per 5 mL / phenylephrine hydrochloride 5 MG per 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566788 | acetaminophen 325 MG per 5 mL / dextromethorphan 10 MG per 5 mL / phenylephrine hydrochloride 5 MG per 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566788 | acetaminophen 325 MG per 5 mL / dextromethorphan 10 MG per 5 mL / phenylephrine hydrochloride 5 MG per 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566789 | chlorhexidine gluconate 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2566790 | benzalkonium / chlorhexidine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2566791 | benzalkonium / chlorhexidine Soap Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2566792 | benzalkonium / chlorhexidine Medicated Liquid Soap | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2566793 | benzalkonium chloride 1 % / chlorhexidine gluconate 0.4 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566793 | benzalkonium chloride 1 % / chlorhexidine gluconate 0.4 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566793 | benzalkonium chloride 1 % / chlorhexidine gluconate 0.4 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566794 | chlorhexidine / climbazole Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2566795 | chlorhexidine / climbazole Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2566796 | chlorhexidine gluconate 3 % / climbazole 0.5 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566796 | chlorhexidine gluconate 3 % / climbazole 0.5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566796 | chlorhexidine gluconate 3 % / climbazole 0.5 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566797 | chlorhexidine / climbazole Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2566798 | chlorhexidine / climbazole Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2566799 | chlorhexidine gluconate 3 % / climbazole 0.5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566799 | chlorhexidine gluconate 3 % / climbazole 0.5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566799 | chlorhexidine gluconate 3 % / climbazole 0.5 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566800 | benzalkonium / chloroxylenol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2566801 | benzalkonium / chloroxylenol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2566802 | benzalkonium / chloroxylenol Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2566803 | benzalkonium chloride 0.13 % / chloroxylenol 0.25 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566803 | benzalkonium chloride 0.13 % / chloroxylenol 0.25 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566803 | benzalkonium chloride 0.13 % / chloroxylenol 0.25 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566804 | benzalkonium / chloroxylenol Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2566805 | benzalkonium chloride 0.13 % / chloroxylenol 0.25 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566805 | benzalkonium chloride 0.13 % / chloroxylenol 0.25 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566805 | benzalkonium chloride 0.13 % / chloroxylenol 0.25 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566806 | alpha tocopherol 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566807 | alpha tocopherol / cholecalciferol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2566808 | alpha tocopherol / cholecalciferol Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2566809 | alpha tocopherol / cholecalciferol Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2566810 | alpha tocopherol / cholecalciferol Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2566811 | alpha tocopherol 10 MG / cholecalciferol 1.25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2566811 | alpha tocopherol 10 MG / cholecalciferol 1.25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2566811 | alpha tocopherol 10 MG / cholecalciferol 1.25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2566812 | dextromethorphan / doxylamine / phenylephrine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2566813 | dextromethorphan / doxylamine / phenylephrine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2566814 | dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG in 15 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566814 | dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566814 | dextromethorphan hydrobromide 10 MG / doxylamine succinate 6.25 MG / phenylephrine hydrochloride 5 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566815 | guaifenesin 6.667 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2566815 | guaifenesin 6.667 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2566816 | dextromethorphan hydrobromide 10 MG / guaiFENesin 100 MG / phenylephrine hydrochloride 5 MG in 15 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566816 | dextromethorphan hydrobromide 10 MG / guaiFENesin 100 MG / phenylephrine hydrochloride 5 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2566816 | dextromethorphan hydrobromide 10 MG / guaiFENesin 100 MG / phenylephrine hydrochloride 5 MG in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566816 | dextromethorphan hydrobromide 10 MG / guaiFENesin 100 MG / phenylephrine hydrochloride 5 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566816 | dextromethorphan hydrobromide 10 MG / guaiFENesin 100 MG / phenylephrine hydrochloride 5 MG in 15 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 2566817 | dextromethorphan hydrobromide 20 MG in 5 mL / phenylephrine hydrochloride 10 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566817 | dextromethorphan hydrobromide 20 MG in 5 mL / phenylephrine hydrochloride 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566817 | dextromethorphan hydrobromide 20 MG in 5 mL / phenylephrine hydrochloride 10 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566818 | hexylresorcinol 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566819 | dextromethorphan / hexylresorcinol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2566820 | dextromethorphan / hexylresorcinol Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2566821 | dextromethorphan / hexylresorcinol Lozenge Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2566822 | dextromethorphan / hexylresorcinol Oral Lozenge | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2566823 | dextromethorphan hydrobromide 5 MG / hexylresorcinol 2 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2566823 | dextromethorphan hydrobromide 5 MG / hexylresorcinol 2 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2566824 | iodine 0.02 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2566825 | iodine / sodium chloride | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2566826 | iodine / sodium chloride Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2566827 | iodine / sodium chloride Nasal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2566828 | iodine / sodium chloride Nasal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2566829 | iodine 0.002 % / sodium chloride 0.9 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566829 | iodine 0.002 % / sodium chloride 0.9 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566829 | iodine 0.002 % / sodium chloride 0.9 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566829 | iodine 0.002 % / sodium chloride 0.9 % Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566830 | allantoin / benzethonium / lidocaine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2566831 | allantoin / benzethonium / lidocaine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2566832 | allantoin / benzethonium / lidocaine Oral Gel Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2566833 | allantoin / benzethonium / lidocaine Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2566834 | allantoin 2 % / benzethonium chloride 0.2 % / lidocaine hydrochloride 4 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566834 | allantoin 2 % / benzethonium chloride 0.2 % / lidocaine hydrochloride 4 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566834 | allantoin 2 % / benzethonium chloride 0.2 % / lidocaine hydrochloride 4 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566835 | menthol 0.056 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2566836 | menthol 5.6 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566836 | menthol 5.6 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566836 | menthol 5.6 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566837 | menthol 6 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566837 | menthol 6 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566837 | menthol 6 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566838 | methyl salicylate 1 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566838 | methyl salicylate 1 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566838 | methyl salicylate 1 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566839 | chloroxylenol / miconazole / salicylic acid | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2566840 | chloroxylenol / miconazole / salicylic acid Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2566841 | chloroxylenol / miconazole / salicylic acid Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2566842 | chloroxylenol 1 % / miconazole nitrate 2 % / salicylic acid 2 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566842 | chloroxylenol 1 % / miconazole nitrate 2 % / salicylic acid 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566842 | chloroxylenol 1 % / miconazole nitrate 2 % / salicylic acid 2 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566843 | dextrose monohydrate 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2566844 | potassium chloride 10 MEQ / dextrose 5 % in 1000 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2566844 | potassium chloride 10 MEQ / dextrose 5 % in 1000 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2566844 | potassium chloride 10 MEQ / dextrose 5 % in 1000 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2566844 | potassium chloride 10 MEQ / dextrose 5 % in 1000 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2566844 | potassium chloride 10 MEQ / dextrose 5 % in 1000 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2566845 | dextrose monohydrate 50 MG/ML / K+ chloride 0.01 MEQ/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566845 | dextrose monohydrate 50 MG/ML / K+ chloride 0.01 MEQ/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566845 | dextrose monohydrate 50 MG/ML / K+ chloride 0.01 MEQ/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566846 | benazepril hydrochloride 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2566847 | spironolactone 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2566848 | benazepril / spironolactone | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2566849 | benazepril / spironolactone Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2566850 | benazepril / spironolactone Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2566851 | benazepril / spironolactone Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2566852 | benazepril / spironolactone Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2566853 | benazepril hydrochloride 2.5 MG / spironolactone 20 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566853 | benazepril hydrochloride 2.5 MG / spironolactone 20 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566853 | benazepril hydrochloride 2.5 MG / spironolactone 20 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566854 | Cardalis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2566855 | benazepril hydrochloride 2.5 MG [Cardalis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2566856 | Cardalis Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2566857 | Cardalis Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2566858 | Cardalis Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2566859 | benazepril / spironolactone Chewable Tablet [Cardalis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2566860 | Cardalis 2.5 MG / 20 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2566860 | Cardalis 2.5 MG / 20 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566860 | Cardalis 2.5 MG / 20 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566861 | spironolactone 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2566862 | benazepril hydrochloride 5 MG / spironolactone 40 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566862 | benazepril hydrochloride 5 MG / spironolactone 40 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566862 | benazepril hydrochloride 5 MG / spironolactone 40 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566863 | benazepril hydrochloride 5 MG [Cardalis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2566864 | Cardalis 5 MG / 40 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2566864 | Cardalis 5 MG / 40 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566864 | Cardalis 5 MG / 40 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566865 | spironolactone 80 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2566866 | benazepril hydrochloride 10 MG / spironolactone 80 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566866 | benazepril hydrochloride 10 MG / spironolactone 80 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566866 | benazepril hydrochloride 10 MG / spironolactone 80 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566867 | benazepril hydrochloride 10 MG [Cardalis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2566868 | Cardalis 10 MG / 80 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2566868 | Cardalis 10 MG / 80 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566868 | Cardalis 10 MG / 80 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566869 | ketoprofen 120 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2566870 | ketoprofen / tulathromycin | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| Concept ID (RxCUI): 2566871 | ketoprofen / tulathromycin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| Concept ID (RxCUI): 2566872 | ketoprofen / tulathromycin Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 2566873 | ketoprofen 120 MG/ML / tulathromycin 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566873 | ketoprofen 120 MG/ML / tulathromycin 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566874 | Draxxin KP | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2566875 | ketoprofen 120 MG/ML / tulathromycin 100 MG/ML [Draxxin KP] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2566876 | Draxxin KP Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2566877 | ketoprofen / tulathromycin Injectable Solution [Draxxin KP] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2566878 | Draxxin KP (ketoprofen 120 MG / tulathromycin 100 MG in 1 ML) Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566878 | Draxxin KP (ketoprofen 120 MG / tulathromycin 100 MG in 1 ML) Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566878 | Draxxin KP (ketoprofen 120 MG / tulathromycin 100 MG in 1 ML) Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2566879 | camphor 160 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2566880 | Capsicum extract 32 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2566881 | levomenthol 48 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2566882 | camphor 160 MG / Capsicum extract 32 MG / levomenthol 48 MG Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2566882 | camphor 160 MG / Capsicum extract 32 MG / levomenthol 48 MG Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2566883 | Arachis hypogaea 2 protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566883 | Arachis hypogaea 2 protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566883 | Arachis hypogaea 2 protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566883 | Arachis hypogaea 2 protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566883 | Arachis hypogaea 2 protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566887 | Bile acid and/or bile acid derivative | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566887 | Bile acid and/or bile acid derivative | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566888 | Bile acid anion | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566888 | Bile acid anion | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566891 | Chenodeoxycholylglycine, conjugated | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566891 | Chenodeoxycholylglycine, conjugated | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566892 | Chlorphenamine polistirex | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566892 | Chlorphenamine polistirex | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566894 | Clostridium tetani toxoid antigen-containing vaccine product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566894 | Clostridium tetani toxoid antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566895 | Coal tar and/or coal tar derivative | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566895 | Coal tar and/or coal tar derivative | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566896 | Coal tar pitch | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566896 | Coal tar pitch | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566897 | Cobalt-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566897 | Cobalt-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566898 | Conjugated bile acids | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566898 | Conjugated bile acids | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566899 | Corynebacterium diphtheriae toxoid antigen-containing vaccine product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566899 | Corynebacterium diphtheriae toxoid antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 25669 | Guanosine diphosphate (GDP) mannose 4,6 dehydratase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 25669 | Guanosine diphosphate (GDP) mannose 4,6 dehydratase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 25669 | Guanosine diphosphate (GDP) mannose 4,6 dehydratase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 25669 | Guanosine diphosphate (GDP) mannose 4,6 dehydratase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566900 | Dacomitinib monohydrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566900 | Dacomitinib monohydrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566901 | Dapoxetine-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566901 | Dapoxetine-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566902 | Agalsidase alfa-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566902 | Agalsidase alfa-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566903 | Dapoxetine-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566903 | Dapoxetine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566905 | Dexketoprofen-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566905 | Dexketoprofen-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566906 | Dihydroxycholanic acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566906 | Dihydroxycholanic acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566906 | Dihydroxycholanic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566907 | Dihydroxycholestanoate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566907 | Dihydroxycholestanoate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566908 | Cat protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566908 | Cat protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566908 | Cat protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566908 | Cat protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566909 | Canis lupus subspecies familiaris protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566909 | Canis lupus subspecies familiaris protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566909 | Canis lupus subspecies familiaris protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566909 | Canis lupus subspecies familiaris protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566910 | Cavia porcellus protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566910 | Cavia porcellus protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566910 | Cavia porcellus protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566910 | Cavia porcellus protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566911 | Doxycycline 40 mg prolonged-release oral capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566911 | Doxycycline 40 mg prolonged-release oral capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566912 | Erythropoiesis stimulating agent | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566912 | Erythropoiesis stimulating agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566912 | Erythropoiesis stimulating agent | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566912 | Erythropoiesis stimulating agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566913 | Erythropoietin receptor agonist-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566913 | Erythropoietin receptor agonist-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566914 | Etelcalcetide calcium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566914 | Etelcalcetide calcium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566915 | Ether structure-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566915 | Ether structure-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566915 | Ether structure-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566915 | Ether structure-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566916 | Ursodeoxycholylglycine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566916 | Ursodeoxycholylglycine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566916 | Ursodeoxycholylglycine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566917 | Equus caballus protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566917 | Equus caballus protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566917 | Equus caballus protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566918 | Mus musculus protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566918 | Mus musculus protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566918 | Mus musculus protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566919 | Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566919 | Hydrocortisone acetate 15 mg/mL and neomycin sulfate 5 mg/mL ear or eye drops | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566921 | COVID-19 inactivated whole antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566921 | COVID-19 inactivated whole antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566921 | COVID-19 inactivated whole antigen vaccine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566921 | COVID-19 inactivated whole antigen vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566921 | COVID-19 inactivated whole antigen vaccine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566922 | Antigen of inactivated whole 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566922 | Antigen of inactivated whole 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566922 | Antigen of inactivated whole 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566922 | Antigen of inactivated whole 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566922 | Antigen of inactivated whole 2019-nCoV | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566922 | Antigen of inactivated whole 2019-nCoV | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566922 | Antigen of inactivated whole 2019-nCoV | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566923 | Antigen of Influenza A virus A/California/7/2009 (H1N1)-like virus strain split virion hemagglutinin | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566923 | Antigen of Influenza A virus A/California/7/2009 (H1N1)-like virus strain split virion hemagglutinin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566923 | Antigen of Influenza A virus A/California/7/2009 (H1N1)-like virus strain split virion hemagglutinin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566923 | Antigen of Influenza A virus A/California/7/2009 (H1N1)-like virus strain split virion hemagglutinin | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566923 | Antigen of Influenza A virus A/California/7/2009 (H1N1)-like virus strain split virion hemagglutinin | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 2566923 | Antigen of Influenza A virus A/California/7/2009 (H1N1)-like virus strain split virion hemagglutinin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566923 | Antigen of Influenza A virus A/California/7/2009 (H1N1)-like virus strain split virion hemagglutinin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566924 | Iodinated contrast media | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566924 | Iodinated contrast media | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566925 | Iodinated contrast media-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566925 | Iodinated contrast media-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566926 | Iotroxic acid-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566926 | Iotroxic acid-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566927 | Ivabradine oxalate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566927 | Ivabradine oxalate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566929 | Melanocortin receptor agonist | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566929 | Melanocortin receptor agonist | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566930 | Melanocortin receptor agonist-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566930 | Melanocortin receptor agonist-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566931 | Muridae protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566931 | Muridae protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566931 | Muridae protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566932 | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566932 | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566933 | Nalmefene-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566933 | Nalmefene-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566934 | Organophosphorus acetylcholinesterase inhibitor | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566934 | Organophosphorus acetylcholinesterase inhibitor | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566935 | Parakeet protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566935 | Parakeet protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566936 | Parathyroid and/or parathyroid hormone derivative-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566936 | Parathyroid and/or parathyroid hormone derivative-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566937 | Parathyroid hormone and/or parathyroid hormone derivative | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566937 | Parathyroid hormone and/or parathyroid hormone derivative | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566938 | Parrot protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566938 | Parrot protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566939 | Peppermint oil 0.2 mL gastro-resistant oral capsule | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566939 | Peppermint oil 0.2 mL gastro-resistant oral capsule | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566940 | Peppermint oil-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566940 | Peppermint oil-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566943 | Pilocarpine nitrate 20 mg/mL eye drops | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566943 | Pilocarpine nitrate 20 mg/mL eye drops | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566944 | Medicinal product containing podophyllotoxin and/or podophyllotoxin derivative and acting as antineoplastic agent (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566944 | Medicinal product containing podophyllotoxin and/or podophyllotoxin derivative and acting as antineoplastic agent (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566945 | Polycarbophil-containing product in oral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566945 | Polycarbophil-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566946 | Product containing protein and/or protein derivative (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566946 | Product containing protein and/or protein derivative (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566947 | Psittacinae protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566947 | Psittacinae protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566948 | PPD - Purified protein derivative - RT23 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566948 | PPD - Purified protein derivative - RT23 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566948 | PPD - Purified protein derivative - RT23 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566949 | PPD - Purified protein derivative - Weybridge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566949 | PPD - Purified protein derivative - Weybridge | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566949 | PPD - Purified protein derivative - Weybridge | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566950 | Product containing purine and/or purine derivative (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566950 | Product containing purine and/or purine derivative (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566951 | Rat protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566951 | Rat protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566952 | Recombinant non-replicating viral vector encoding SARS-CoV-2 spike protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566952 | Recombinant non-replicating viral vector encoding SARS-CoV-2 spike protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566952 | Recombinant non-replicating viral vector encoding SARS-CoV-2 spike protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566953 | Rurioctocog alfa | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566953 | Rurioctocog alfa | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566954 | Product containing precisely sennoside B 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566954 | Product containing precisely sennoside B 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566955 | Substance with sulfone structure and antimycobacterial mechanism of action (substance) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566955 | Substance with sulfone structure and antimycobacterial mechanism of action (substance) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566956 | Sulfonyluric hypoglycemic | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566956 | Sulfonyluric hypoglycemic | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566956 | Sulfonyluric hypoglycemic | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 2566957 | Synthetic bile acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566957 | Synthetic bile acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566958 | Taurine salt of bile acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566958 | Taurine salt of bile acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566959 | Product containing technetium-99m in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566959 | Product containing technetium-99m in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566960 | Trihydroxy bile acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566960 | Trihydroxy bile acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566961 | Trihydroxycoprostanic acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566961 | Trihydroxycoprostanic acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566962 | Product containing vitamin (product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566962 | Product containing vitamin (product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566963 | Oryctolagus cuniculus protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566963 | Oryctolagus cuniculus protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566963 | Oryctolagus cuniculus protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566963 | Oryctolagus cuniculus protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566963 | Oryctolagus cuniculus protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566964 | Biguanide oral hypoglycaemic agent | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 2566964 | Biguanide oral hypoglycaemic agent | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566964 | Biguanide oral hypoglycaemic agent | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566965 | Budesonide 9 mg gastro-resistant oral granules sachet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566965 | Budesonide 9 mg gastro-resistant oral granules sachet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566966 | Phenylalanine ammonia-lyase-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566966 | Phenylalanine ammonia-lyase-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566967 | Calcium phosphate- and carmellose-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566967 | Calcium phosphate- and carmellose-containing product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566967 | Calcium phosphate- and carmellose-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566968 | Calcium phosphate-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566968 | Calcium phosphate-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566969 | Carbetocin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566969 | Carbetocin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566970 | Phosphorus-32-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566970 | Phosphorus-32-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566971 | Plant material-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566971 | Plant material-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566972 | Povidone-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566972 | Povidone-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566973 | Prednisolone acetate 1.2 mg/mL eye drops | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566973 | Prednisolone acetate 1.2 mg/mL eye drops | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566974 | Aluminium-containing product in oromucosal dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566974 | Aluminium-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566974 | Aluminium-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566975 | Epoetin theta-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566975 | Epoetin theta-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566976 | Epoetin zeta-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566976 | Epoetin zeta-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566977 | Ampicillin 25 mg/mL and flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566977 | Ampicillin 25 mg/mL and flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566977 | Ampicillin 25 mg/mL and flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566978 | Fluorescein sodium 20 mg/mL eye drops | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566978 | Fluorescein sodium 20 mg/mL eye drops | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566979 | Fluoride-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566979 | Fluoride-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566980 | Gadobenic acid-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566980 | Gadobenic acid-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566981 | Animal material-containing product | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566981 | Animal material-containing product | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566982 | Gadobutrol-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566982 | Gadobutrol-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566983 | Gadoxetic acid-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566983 | Gadoxetic acid-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566984 | Oxybuprocaine hydrochloride 4 mg/mL eye drops | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566984 | Oxybuprocaine hydrochloride 4 mg/mL eye drops | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2566984 | Oxybuprocaine hydrochloride 4 mg/mL eye drops | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566985 | Product containing precisely theophylline (as theophylline sodium glycinate) 11 milligram/1 milliliter conventional release oral solution (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2566985 | Product containing precisely theophylline (as theophylline sodium glycinate) 11 milligram/1 milliliter conventional release oral solution (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566986 | Levofloxacin 5 mg/mL solution for infusion | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2566986 | Levofloxacin 5 mg/mL solution for infusion | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567 | L-citrulline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2567 | L-citrulline | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2567 | L-citrulline | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 2567 | L-citrulline | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 2567 | L-citrulline | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2567 | L-citrulline | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 25670 | Guanosine diphosphate (GDP) mannose dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 25670 | Guanosine diphosphate (GDP) mannose dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 25670 | Guanosine diphosphate (GDP) mannose dehydrogenase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 25670 | Guanosine diphosphate (GDP) mannose dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567015 | dodecylphosphocholine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 25671 | Dolichyl-phosphate mannosyltransferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 25671 | Dolichyl-phosphate mannosyltransferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 25672 | Guanosine diphosphate-mannose 3,5-epimerase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 25672 | Guanosine diphosphate-mannose 3,5-epimerase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 25672 | Guanosine diphosphate-mannose 3,5-epimerase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567226 | belzutifan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 2567227 | belzutifan 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2567228 | belzutifan Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2567229 | belzutifan Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2567230 | belzutifan Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2567231 | belzutifan 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2567231 | belzutifan 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2567232 | Welireg | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2567233 | belzutifan 40 MG [Welireg] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2567234 | Welireg Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2567235 | Welireg Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2567236 | belzutifan Oral Tablet [Welireg] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2567237 | Welireg 40 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2567237 | Welireg 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2567237 | Welireg 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2567315 | Budesonide 160 microgram and formoterol fumarate dihydrate 4.5 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567315 | Budesonide 160 microgram and formoterol fumarate dihydrate 4.5 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567316 | Budesonide 80 microgram and formoterol fumarate dihydrate 4.5 microgram/actuation powder for inhalation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567316 | Budesonide 80 microgram and formoterol fumarate dihydrate 4.5 microgram/actuation powder for inhalation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567317 | Gentamicin (as gentamicin sulfate) 3 mg/mL ear or eye drops | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567317 | Gentamicin (as gentamicin sulfate) 3 mg/mL ear or eye drops | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567318 | Neomycin sulfate 5 mg/mL and prednisolone sodium phosphate 5 mg/mL ear or eye drops | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567318 | Neomycin sulfate 5 mg/mL and prednisolone sodium phosphate 5 mg/mL ear or eye drops | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567319 | Prednisolone sodium phosphate 5 mg/mL ear or eye drops | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567319 | Prednisolone sodium phosphate 5 mg/mL ear or eye drops | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567321 | Tritocin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2567322 | triamcinolone acetonide 0.0005 MG/MG [Tritocin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2567323 | Tritocin Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2567324 | triamcinolone Topical Ointment [Tritocin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2567325 | Tritocin 0.05 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2567325 | Tritocin 0.05 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2567325 | Tritocin 0.05 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2567325 | Tritocin 0.05 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2567326 | Desrx | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 2567327 | desonide 0.0005 MG/MG [Desrx] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| Concept ID (RxCUI): 2567328 | Desrx Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| Concept ID (RxCUI): 2567329 | desonide Topical Gel [Desrx] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2567330 | DesRx 0.05 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| Concept ID (RxCUI): 2567330 | DesRx 0.05 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2567330 | DesRx 0.05 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2567330 | DesRx 0.05 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2567331 | mordant yellow 10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2567332 | Tetragonia tetragonoides whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2567405 | Abatacept 125 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567405 | Abatacept 125 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567406 | Acetylcysteine 200 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567406 | Acetylcysteine 200 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567407 | Aflibercept 40 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567407 | Aflibercept 40 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567408 | Albumin human 200 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567408 | Albumin human 200 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567409 | Albumin human 250 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567409 | Albumin human 250 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567410 | Albumin human 50 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567410 | Albumin human 50 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567411 | Alirocumab 150 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567411 | Alirocumab 150 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567412 | Alirocumab 75 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567412 | Alirocumab 75 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567413 | Aminophylline hydrate 25 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567413 | Aminophylline hydrate 25 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567414 | Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567414 | Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567415 | Anhydrous glucose 40 mg/mL and potassium chloride 2 mg/mL and sodium chloride 1.8 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567415 | Anhydrous glucose 40 mg/mL and potassium chloride 2 mg/mL and sodium chloride 1.8 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567416 | Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567416 | Anhydrous glucose 40 mg/mL and potassium chloride 3 mg/mL and sodium chloride 1.8 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567417 | Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 4.5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567417 | Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 4.5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567418 | Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567418 | Anhydrous glucose 50 mg/mL and potassium chloride 1.5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567419 | Anhydrous glucose 50 mg/mL and potassium chloride 2 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567419 | Anhydrous glucose 50 mg/mL and potassium chloride 2 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567420 | Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567420 | Anhydrous glucose 50 mg/mL and potassium chloride 3 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567421 | Argatroban 100 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567421 | Argatroban 100 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567422 | Arsenic trioxide 1 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567422 | Arsenic trioxide 1 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567423 | Arsenic trioxide 2 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567423 | Arsenic trioxide 2 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567424 | Benralizumab 30 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567424 | Benralizumab 30 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567425 | Botulinum toxin type B 5000 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567425 | Botulinum toxin type B 5000 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567426 | Brodalumab 140 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567426 | Brodalumab 140 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567427 | Bupivacaine hydrochloride 1.25 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567427 | Bupivacaine hydrochloride 1.25 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567428 | Cabotegravir 200 mg/mL prolonged-release suspension for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567428 | Cabotegravir 200 mg/mL prolonged-release suspension for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567429 | Carbetocin 100 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567429 | Carbetocin 100 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567430 | Casirivimab 120 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567430 | Casirivimab 120 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567431 | Casirivimab 60 mg/mL and imdevimab 60 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567431 | Casirivimab 60 mg/mL and imdevimab 60 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567432 | Ceftazidime 3 g powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567432 | Ceftazidime 3 g powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567433 | Cefuroxime (as cefuroxime sodium) 15 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567433 | Cefuroxime (as cefuroxime sodium) 15 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567434 | Cefuroxime (as cefuroxime sodium) 30 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567434 | Cefuroxime (as cefuroxime sodium) 30 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567435 | Certolizumab pegol 200 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567435 | Certolizumab pegol 200 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567436 | Cetuximab 2 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567436 | Cetuximab 2 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567437 | Cidofovir 75 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567437 | Cidofovir 75 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567438 | Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567438 | Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567439 | Cladribine 1 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567439 | Cladribine 1 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567440 | Clodronate disodium 60 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567440 | Clodronate disodium 60 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567441 | Cyclophosphamide 200 mg powder for solution for injection vial | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567441 | Cyclophosphamide 200 mg powder for solution for injection vial | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567442 | Darbepoetin alfa 100 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567442 | Darbepoetin alfa 100 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567443 | Darbepoetin alfa 200 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567443 | Darbepoetin alfa 200 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567444 | Darbepoetin alfa 25 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567444 | Darbepoetin alfa 25 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567445 | Darbepoetin alfa 40 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567445 | Darbepoetin alfa 40 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567446 | Denosumab 70 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567446 | Denosumab 70 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567448 | Dexketoprofen (as dexketoprofen trometamol) 25 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2567448 | Dexketoprofen (as dexketoprofen trometamol) 25 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567448 | Dexketoprofen (as dexketoprofen trometamol) 25 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567449 | Dopamine hydrochloride 160 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567449 | Dopamine hydrochloride 160 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567450 | Droperidol 2.5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567450 | Droperidol 2.5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567451 | Emicizumab 150 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567451 | Emicizumab 150 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567452 | Emicizumab 30 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567452 | Emicizumab 30 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567453 | Epoetin theta 10000 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567453 | Epoetin theta 10000 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567454 | Epoetin theta 2000 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567454 | Epoetin theta 2000 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567455 | Epoetin theta 20000 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567455 | Epoetin theta 20000 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567456 | Epoetin theta 30000 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567456 | Epoetin theta 30000 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567457 | Epoetin theta 4000 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567457 | Epoetin theta 4000 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567458 | Epoetin theta 6000 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567458 | Epoetin theta 6000 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567459 | Epoetin theta 8000 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567459 | Epoetin theta 8000 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567460 | Epoetin zeta 10000 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567460 | Epoetin zeta 10000 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567461 | Epoetin zeta 3333.333 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567461 | Epoetin zeta 3333.333 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567462 | Epoetin zeta 40000 unit/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567462 | Epoetin zeta 40000 unit/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567463 | Eptifibatide 750 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567463 | Eptifibatide 750 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567464 | Erenumab 140 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567464 | Erenumab 140 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567465 | Erenumab 70 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567465 | Erenumab 70 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567467 | Eribulin (as eribulin mesilate) 440 microgram/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2567467 | Eribulin (as eribulin mesilate) 440 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567467 | Eribulin (as eribulin mesilate) 440 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567468 | Etelcalcetide (as etelcalcetide hydrochloride) 5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567468 | Etelcalcetide (as etelcalcetide hydrochloride) 5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567469 | Evolocumab 120 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567469 | Evolocumab 120 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567470 | Evolocumab 140 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567470 | Evolocumab 140 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567471 | Exenatide 250 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567471 | Exenatide 250 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567472 | Filgrastim 600 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567472 | Filgrastim 600 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567473 | Filgrastim 960 microgram/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567473 | Filgrastim 960 microgram/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567474 | Foscarnet sodium 24 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567474 | Foscarnet sodium 24 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567475 | Fremanezumab 150 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567475 | Fremanezumab 150 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567476 | Gadobenic acid (as meglumine gadobenate) 334 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567476 | Gadobenic acid (as meglumine gadobenate) 334 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2567476 | Gadobenic acid (as meglumine gadobenate) 334 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567478 | Gadobutrol 604.72 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567478 | Gadobutrol 604.72 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567479 | Gadoxetate disodium 181.43 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567479 | Gadoxetate disodium 181.43 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567480 | Glatiramer acetate 40 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567480 | Glatiramer acetate 40 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567481 | Golimumab 100 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567481 | Golimumab 100 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567482 | Hexastarch 60 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567482 | Hexastarch 60 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567483 | Imdevimab 120 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567483 | Imdevimab 120 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567484 | Irinotecan hydrochloride trihydrate 20 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567484 | Irinotecan hydrochloride trihydrate 20 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567485 | Iron (as ferric carboxymaltose) 50 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567485 | Iron (as ferric carboxymaltose) 50 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567486 | Levofloxacin 5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567486 | Levofloxacin 5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567487 | Linezolid 2 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567487 | Linezolid 2 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567488 | Lumasiran 189 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567488 | Lumasiran 189 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567489 | Mannitol 200 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567489 | Mannitol 200 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567490 | Metronidazole 5 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567490 | Metronidazole 5 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567491 | Moxifloxacin (as moxifloxacin hydrochloride) 1.6 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567491 | Moxifloxacin (as moxifloxacin hydrochloride) 1.6 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567493 | Noradrenaline (as noradrenaline bitartrate) 1 mg/mL solution for injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2567493 | Noradrenaline (as noradrenaline bitartrate) 1 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567493 | Noradrenaline (as noradrenaline bitartrate) 1 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567494 | Nusinersen (as nusinersen sodium) 2.4 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567494 | Nusinersen (as nusinersen sodium) 2.4 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567495 | Potassium chloride 1.5 mg/mL and sodium chloride 9 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567495 | Potassium chloride 1.5 mg/mL and sodium chloride 9 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567496 | Potassium chloride 2 mg/mL and sodium chloride 9 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567496 | Potassium chloride 2 mg/mL and sodium chloride 9 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567497 | Potassium chloride 3 mg/mL and sodium chloride 9 mg/mL solution for injection | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567497 | Potassium chloride 3 mg/mL and sodium chloride 9 mg/mL solution for injection | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567498 | Product containing precisely rilpivirine 300 milligram/1 milliliter prolonged-release suspension for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567498 | Product containing precisely rilpivirine 300 milligram/1 milliliter prolonged-release suspension for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567499 | Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567499 | Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567500 | Product containing precisely sotrovimab 62.5 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567500 | Product containing precisely sotrovimab 62.5 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567501 | Product containing precisely tacrolimus 5 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567501 | Product containing precisely tacrolimus 5 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567502 | Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567502 | Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567503 | Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567503 | Product containing precisely trastuzumab emtansine 160 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567504 | Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 2567504 | Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for injection (clinical drug) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 2567688 | Rosa canina seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2568104 | Hibiscus sabdariffa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2568106 | sesame oil unsaponifiables | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 2568108 | ethanol 73.7 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2568108 | ethanol 73.7 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2568108 | ethanol 73.7 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2568108 | ethanol 73.7 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2568110 | camphor 96 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2568111 | levomenthol 76.8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2568112 | methyl salicylate 57.6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2568113 | camphor 96 MG / levomenthol 76.8 MG / methyl salicylate 57.6 MG Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 2568113 | camphor 96 MG / levomenthol 76.8 MG / methyl salicylate 57.6 MG Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2568116 | salicylic acid 0.018 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2568117 | salicylic acid 1.8 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2568117 | salicylic acid 1.8 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2568117 | salicylic acid 1.8 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2568118 | amphetamine sulfate 2.5 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2568118 | amphetamine sulfate 2.5 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2568119 | amphetamine sulfate 2.5 MG [Evekeo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2568120 | EVEKEO 2.5 MG Disintegrating Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2568120 | EVEKEO 2.5 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2568120 | EVEKEO 2.5 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2568122 | chlorhexidine gluconate 1.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 2568123 | chlorhexidine gluconate 0.15 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2568123 | chlorhexidine gluconate 0.15 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2568123 | chlorhexidine gluconate 0.15 % Otic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 2568124 | Otodine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 2568125 | chlorhexidine gluconate 1.5 MG/ML [Otodine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| Concept ID (RxCUI): 2568126 | Otodine Otic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| Concept ID (RxCUI): 2568127 | chlorhexidine Otic Solution [Otodine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2568128 | Otodine 0.15 % Otic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| Concept ID (RxCUI): 2568128 | Otodine 0.15 % Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 2568128 | Otodine 0.15 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2568128 | Otodine 0.15 % Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 2568566 | copper sulfate 0.15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2568567 | manganese sulfate 0.00822 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2568568 | selenious acid 0.0098 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2568569 | zinc sulfate 2.47 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 2568570 | copper sulfate / manganese sulfate / selenious acid / zinc sulfate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 2568571 | copper sulfate / manganese sulfate / selenious acid / zinc sulfate Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| Concept ID (RxCUI): 2568572 | copper sulfate / manganese sulfate / selenious acid / zinc sulfate Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 2568573 | copper sulfate 150 MCG (copper 60 MCG) / manganese sulfate 8.22 MCG (manganese 3 MCG) / selenious acid 9.8 MCG (selenium 6 MCG) / zinc sulfate 2470 MCG (zinc 1000 MCG) in 1 ml Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 2568573 | copper sulfate 150 MCG (copper 60 MCG) / manganese sulfate 8.22 MCG (manganese 3 MCG) / selenious acid 9.8 MCG (selenium 6 MCG) / zinc sulfate 2470 MCG (zinc 1000 MCG) in 1 ml Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 2568573 | cop |